'Xeroderma'
(id=17342228 ; fe=Xeroderma ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=217 creation date=2022-01-10 touchdate=2026-04-17 08:16:05.000)

≈ 1692 relations sortantes Xeroderma -- r_associated #0: 30 / 1 -> xeroderma pigmentosum n1=Xeroderma | n2=xeroderma pigmentosum | rel=r_associated | relid=0 | w=30 Xeroderma -- r_associated #0: 20 / 0.667 -> autres manifestations de l'avitaminose a n1=Xeroderma | n2=autres manifestations de l'avitaminose a | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> desquamée n1=Xeroderma | n2=desquamée | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> desquamer n1=Xeroderma | n2=desquamer | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:'ice-pick marks' n1=Xeroderma | n2=en:'ice-pick marks' | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:'orange peel' skin n1=Xeroderma | n2=en:'orange peel' skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:'orange peel' skin (large pores) n1=Xeroderma | n2=en:'orange peel' skin (large pores) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:1-5mm dark lentigines (especially neck and trunk) n1=Xeroderma | n2=en:1-5mm dark lentigines (especially neck and trunk) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:1. yellowish, flat papules (neck, antecubital and popliteal fossae, axillae, inguinal, and periumbilical areas) n1=Xeroderma | n2=en:1. yellowish, flat papules (neck, antecubital and popliteal fossae, axillae, inguinal, and periumbilical areas) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:2. yellowish, flat plaques n1=Xeroderma | n2=en:2. yellowish, flat plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:3. lax, wrinkled skin n1=Xeroderma | n2=en:3. lax, wrinkled skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aberrant melanosome maturation n1=Xeroderma | n2=en:aberrant melanosome maturation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aberrant skin dimples (elbows and knees) n1=Xeroderma | n2=en:aberrant skin dimples (elbows and knees) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abnormal alignment of collagen bundles n1=Xeroderma | n2=en:abnormal alignment of collagen bundles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abnormal blistering of the skin n1=Xeroderma | n2=en:abnormal blistering of the skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abnormal finger flexion creases n1=Xeroderma | n2=en:abnormal finger flexion creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abnormal granulation tissue n1=Xeroderma | n2=en:abnormal granulation tissue | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abnormal sensitivity to uvb wavelengths by radiation monochromator skin testing n1=Xeroderma | n2=en:abnormal sensitivity to uvb wavelengths by radiation monochromator skin testing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abnormal subcutaneous fat tissue distribution n1=Xeroderma | n2=en:abnormal subcutaneous fat tissue distribution | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abnormal sweating due to autonomic dysfunction n1=Xeroderma | n2=en:abnormal sweating due to autonomic dysfunction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abrasion/scratch/blister n1=Xeroderma | n2=en:abrasion/scratch/blister | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abscess formation n1=Xeroderma | n2=en:abscess formation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abscess of skin and/or subcutaneous tissue n1=Xeroderma | n2=en:abscess of skin and/or subcutaneous tissue | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:abscesses (in skin folds that carry terminal hairs and apocrine glands including axillae, groin, anal fold, mons pubis, and scalp, but not face) n1=Xeroderma | n2=en:abscesses (in skin folds that carry terminal hairs and apocrine glands including axillae, groin, anal fold, mons pubis, and scalp, but not face) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of all distal creases of second to fifth digits n1=Xeroderma | n2=en:absence of all distal creases of second to fifth digits | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of dermopathy n1=Xeroderma | n2=en:absence of dermopathy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of interphalangeal creases n1=Xeroderma | n2=en:absence of interphalangeal creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of normal rete ridge pattern n1=Xeroderma | n2=en:absence of normal rete ridge pattern | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of pretibial myxedema n1=Xeroderma | n2=en:absence of pretibial myxedema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of skin creases over distal interphalangeal (dip) joints n1=Xeroderma | n2=en:absence of skin creases over distal interphalangeal (dip) joints | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of skin creases over proximal interphalangeal (pip) joints n1=Xeroderma | n2=en:absence of skin creases over proximal interphalangeal (pip) joints | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absence of subcutaneous fat n1=Xeroderma | n2=en:absence of subcutaneous fat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent axonal flare response after intradermal histamine injection n1=Xeroderma | n2=en:absent axonal flare response after intradermal histamine injection | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent dermal ridges n1=Xeroderma | n2=en:absent dermal ridges | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent distal interphalangeal creases n1=Xeroderma | n2=en:absent distal interphalangeal creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent dorsal skin creases over affected joints n1=Xeroderma | n2=en:absent dorsal skin creases over affected joints | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent fingerprints n1=Xeroderma | n2=en:absent fingerprints | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent phalangeal crease n1=Xeroderma | n2=en:absent phalangeal crease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent skin pigmentation n1=Xeroderma | n2=en:absent skin pigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:absent-mild skin hyperextensibility n1=Xeroderma | n2=en:absent-mild skin hyperextensibility | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acanthosis n1=Xeroderma | n2=en:acanthosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acanthosis nigricans n1=Xeroderma | n2=en:acanthosis nigricans | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acanthosis nigricans (in some patients) n1=Xeroderma | n2=en:acanthosis nigricans (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acanthosis nigricans (uncommon) n1=Xeroderma | n2=en:acanthosis nigricans (uncommon) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acanthosis nigricans in patients with diabetes n1=Xeroderma | n2=en:acanthosis nigricans in patients with diabetes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acanthosis nigricans, axillary (in male patient) n1=Xeroderma | n2=en:acanthosis nigricans, axillary (in male patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:accumulation of melanosomes in melanocytes n1=Xeroderma | n2=en:accumulation of melanosomes in melanocytes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acne n1=Xeroderma | n2=en:acne | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acne, severe comedogenic n1=Xeroderma | n2=en:acne, severe comedogenic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acneform facial lesions n1=Xeroderma | n2=en:acneform facial lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acneiform lesions (rare) n1=Xeroderma | n2=en:acneiform lesions (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acral keratosis n1=Xeroderma | n2=en:acral keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acral ulcers n1=Xeroderma | n2=en:acral ulcers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acral violaceous plaques and nodules n1=Xeroderma | n2=en:acral violaceous plaques and nodules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acrocyanosis n1=Xeroderma | n2=en:acrocyanosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acrocyanosis of the feet (in some patients) n1=Xeroderma | n2=en:acrocyanosis of the feet (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acrodermatitis enteropathica, transient, seen in breastfed offspring of affected mothers n1=Xeroderma | n2=en:acrodermatitis enteropathica, transient, seen in breastfed offspring of affected mothers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acrogeria n1=Xeroderma | n2=en:acrogeria | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:acrokeratosis verruciformis-like lesions on dorsum of hands n1=Xeroderma | n2=en:acrokeratosis verruciformis-like lesions on dorsum of hands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:actinic (solar) keratosis n1=Xeroderma | n2=en:actinic (solar) keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:adipose tissue deposition n1=Xeroderma | n2=en:adipose tissue deposition | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:administration related reaction n1=Xeroderma | n2=en:administration related reaction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:affects distal limb and scalp n1=Xeroderma | n2=en:affects distal limb and scalp | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:affects limbs and trunk n1=Xeroderma | n2=en:affects limbs and trunk | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:albinism n1=Xeroderma | n2=en:albinism | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:albinoidism n1=Xeroderma | n2=en:albinoidism | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:albopapuloid lesions may occur n1=Xeroderma | n2=en:albopapuloid lesions may occur | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:angiokeratoma n1=Xeroderma | n2=en:angiokeratoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:angiokeratoma corporis diffusum n1=Xeroderma | n2=en:angiokeratoma corporis diffusum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:angiokeratomas (soles) n1=Xeroderma | n2=en:angiokeratomas (soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:angiomatous lesions on the fingers, persistent n1=Xeroderma | n2=en:angiomatous lesions on the fingers, persistent | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:anhidrosis n1=Xeroderma | n2=en:anhidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:anhidrosis (in patients with hsan2d) n1=Xeroderma | n2=en:anhidrosis (in patients with hsan2d) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:anhidrosis of the trunk and limbs 100% of the time n1=Xeroderma | n2=en:anhidrosis of the trunk and limbs 100% of the time | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:anhidrosis over skin lesions (rare) n1=Xeroderma | n2=en:anhidrosis over skin lesions (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:anhidrosis, patchy n1=Xeroderma | n2=en:anhidrosis, patchy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:anhidrosis, patchy, in some patients n1=Xeroderma | n2=en:anhidrosis, patchy, in some patients | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:anhydrotic ectodermal dysplasias n1=Xeroderma | n2=en:anhydrotic ectodermal dysplasias | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:animal/human bite n1=Xeroderma | n2=en:animal/human bite | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:annular erythematous edematous plaques n1=Xeroderma | n2=en:annular erythematous edematous plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:annular lesions (3 mm to 1 cm in diameter) located on the face, neck, trunk and limbs n1=Xeroderma | n2=en:annular lesions (3 mm to 1 cm in diameter) located on the face, neck, trunk and limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:antecubial webbing n1=Xeroderma | n2=en:antecubial webbing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aplasia cutis congenita n1=Xeroderma | n2=en:aplasia cutis congenita | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aplasia cutis congenita on trunk or limbs n1=Xeroderma | n2=en:aplasia cutis congenita on trunk or limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aplasia cutis congenita over posterior parietal area n1=Xeroderma | n2=en:aplasia cutis congenita over posterior parietal area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aplasia cutis of the scalp n1=Xeroderma | n2=en:aplasia cutis of the scalp | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aplasia of the sweat glands n1=Xeroderma | n2=en:aplasia of the sweat glands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:aplasia/hypoplastia of the eccrine sweat glands n1=Xeroderma | n2=en:aplasia/hypoplastia of the eccrine sweat glands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:apparent death n1=Xeroderma | n2=en:apparent death | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:arborescent papillomas (axillae, periumbilical area, anus, vulva) n1=Xeroderma | n2=en:arborescent papillomas (axillae, periumbilical area, anus, vulva) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:areas of hypopigmentation and hyperpigmentation that do not follow blaschko lines (in some patients) n1=Xeroderma | n2=en:areas of hypopigmentation and hyperpigmentation that do not follow blaschko lines (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:asymmetric, linear skin defects (anterior face and neck) n1=Xeroderma | n2=en:asymmetric, linear skin defects (anterior face and neck) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:asymptomatic soft white spongy mucosal plaques with thick folded surfaces n1=Xeroderma | n2=en:asymptomatic soft white spongy mucosal plaques with thick folded surfaces | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atopic dermatitis/eczema n1=Xeroderma | n2=en:atopic dermatitis/eczema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atopy n1=Xeroderma | n2=en:atopy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atrophic scar n1=Xeroderma | n2=en:atrophic scar | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atrophic scarring (less common) n1=Xeroderma | n2=en:atrophic scarring (less common) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atrophic scarring (rare) n1=Xeroderma | n2=en:atrophic scarring (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atrophic scarring, severe n1=Xeroderma | n2=en:atrophic scarring, severe | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atrophic skin over ears n1=Xeroderma | n2=en:atrophic skin over ears | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atrophy n1=Xeroderma | n2=en:atrophy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atypical nevi (>5mm with irregular edge and pigmentation) n1=Xeroderma | n2=en:atypical nevi (>5mm with irregular edge and pigmentation) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:atypical nevi often present in non-sun exposed areas n1=Xeroderma | n2=en:atypical nevi often present in non-sun exposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:autoamputation of digits n1=Xeroderma | n2=en:autoamputation of digits | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:autonomic nervous system disorders n1=Xeroderma | n2=en:autonomic nervous system disorders | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:autoresuscitation n1=Xeroderma | n2=en:autoresuscitation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:axillary apocrine gland hypoplasia n1=Xeroderma | n2=en:axillary apocrine gland hypoplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:axillary freckling n1=Xeroderma | n2=en:axillary freckling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:axillary pterygia n1=Xeroderma | n2=en:axillary pterygia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:axillary pterygium, bilateral (in some patients) n1=Xeroderma | n2=en:axillary pterygium, bilateral (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:baldness/losing hair n1=Xeroderma | n2=en:baldness/losing hair | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:basal cell layer contains clumped keratin filaments n1=Xeroderma | n2=en:basal cell layer contains clumped keratin filaments | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:basal cell nevus n1=Xeroderma | n2=en:basal cell nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:basaloid follicular harmartomas n1=Xeroderma | n2=en:basaloid follicular harmartomas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bathing suit distribution of ichthyosis (in some patients) n1=Xeroderma | n2=en:bathing suit distribution of ichthyosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bilateral palmar simian creases n1=Xeroderma | n2=en:bilateral palmar simian creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bilateral single palmar creases n1=Xeroderma | n2=en:bilateral single palmar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bilateral single transverse palmar creases n1=Xeroderma | n2=en:bilateral single transverse palmar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bilateral transverse palmar creases n1=Xeroderma | n2=en:bilateral transverse palmar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blanching of the fingers in response to cold n1=Xeroderma | n2=en:blanching of the fingers in response to cold | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blister n1=Xeroderma | n2=en:blister | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering (fingers, toes, pinnae) n1=Xeroderma | n2=en:blistering (fingers, toes, pinnae) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering at acral sites n1=Xeroderma | n2=en:blistering at acral sites | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering erythematous rash n1=Xeroderma | n2=en:blistering erythematous rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering may be generalized or localized n1=Xeroderma | n2=en:blistering may be generalized or localized | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering occurs in clusters ('herpetiform', 'arcuate') n1=Xeroderma | n2=en:blistering occurs in clusters ('herpetiform', 'arcuate') | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering of hands, elbows, feet, knees n1=Xeroderma | n2=en:blistering of hands, elbows, feet, knees | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering of palms in hot weather (in some patients) n1=Xeroderma | n2=en:blistering of palms in hot weather (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering skin lesions, recurrent n1=Xeroderma | n2=en:blistering skin lesions, recurrent | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering, generalized, neonatal onset n1=Xeroderma | n2=en:blistering, generalized, neonatal onset | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering, generalized, recurrent (occurs after mild physical trauma) n1=Xeroderma | n2=en:blistering, generalized, recurrent (occurs after mild physical trauma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering, generalized, recurrent, severe (occurs after mild physical trauma) n1=Xeroderma | n2=en:blistering, generalized, recurrent, severe (occurs after mild physical trauma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering, mild (occurs mainly on ankles and feet and in response to trauma) n1=Xeroderma | n2=en:blistering, mild (occurs mainly on ankles and feet and in response to trauma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering, recurrent n1=Xeroderma | n2=en:blistering, recurrent | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blistering, recurrent, of the palms and soles n1=Xeroderma | n2=en:blistering, recurrent, of the palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blisters in sun-exposed areas n1=Xeroderma | n2=en:blisters in sun-exposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blood vessel structure of skin n1=Xeroderma | n2=en:blood vessel structure of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bloody discharge n1=Xeroderma | n2=en:bloody discharge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blotching pigmentation of the skin (in older children) n1=Xeroderma | n2=en:blotching pigmentation of the skin (in older children) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:blue nevus n1=Xeroderma | n2=en:blue nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bluish skin nodules n1=Xeroderma | n2=en:bluish skin nodules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bluish-red border demarcating transition to normal skin n1=Xeroderma | n2=en:bluish-red border demarcating transition to normal skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:body substance discharge n1=Xeroderma | n2=en:body substance discharge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:breaks in epidermal ridges of palms and fingers n1=Xeroderma | n2=en:breaks in epidermal ridges of palms and fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bridge between vertical and transverse proximal palmar flexion creases n1=Xeroderma | n2=en:bridge between vertical and transverse proximal palmar flexion creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bright copper-red coloration of skin (in darker-skinned individuals) n1=Xeroderma | n2=en:bright copper-red coloration of skin (in darker-skinned individuals) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:brown macules in a reticulate pattern (rare) n1=Xeroderma | n2=en:brown macules in a reticulate pattern (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:brown, warty keratotic papules (trunk, scalp, forehead, flexural areas) n1=Xeroderma | n2=en:brown, warty keratotic papules (trunk, scalp, forehead, flexural areas) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:brownish macular and lentiginous lesions, disseminated, present on extremities, trunk, and neck n1=Xeroderma | n2=en:brownish macular and lentiginous lesions, disseminated, present on extremities, trunk, and neck | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:brownish-black macules on dorsa of hands and feet (in some patients) n1=Xeroderma | n2=en:brownish-black macules on dorsa of hands and feet (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bruise/contusion intact skin n1=Xeroderma | n2=en:bruise/contusion intact skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:bullous, pustular dermatitis of extremities, oral, anal, and genital areas n1=Xeroderma | n2=en:bullous, pustular dermatitis of extremities, oral, anal, and genital areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:burning sensation n1=Xeroderma | n2=en:burning sensation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe au lait spot n1=Xeroderma | n2=en:cafe au lait spot | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe au lait spots (in some patients) n1=Xeroderma | n2=en:cafe au lait spots (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe au lait spots on trunk and extremities n1=Xeroderma | n2=en:cafe au lait spots on trunk and extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe au lait spots, multiple n1=Xeroderma | n2=en:cafe au lait spots, multiple | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe-au-lait spot (in 1/4 patients) n1=Xeroderma | n2=en:cafe-au-lait spot (in 1/4 patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe-au-lait spots (93%) n1=Xeroderma | n2=en:cafe-au-lait spots (93%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe-au-lait spots may or may not be present n1=Xeroderma | n2=en:cafe-au-lait spots may or may not be present | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe-au-lait spots on chest and abdomen (rare) n1=Xeroderma | n2=en:cafe-au-lait spots on chest and abdomen (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cafe-noir spots (trunk) n1=Xeroderma | n2=en:cafe-noir spots (trunk) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:calcification may occur n1=Xeroderma | n2=en:calcification may occur | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:calcified, ulcerating nodules n1=Xeroderma | n2=en:calcified, ulcerating nodules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:calcinosis cutis n1=Xeroderma | n2=en:calcinosis cutis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:calcinosis cutis metastatica n1=Xeroderma | n2=en:calcinosis cutis metastatica | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:calluses on weight-bearing areas of soles n1=Xeroderma | n2=en:calluses on weight-bearing areas of soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:candida diaper dermatitis n1=Xeroderma | n2=en:candida diaper dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:candidiasis n1=Xeroderma | n2=en:candidiasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:capillary hemangioma (forehead) n1=Xeroderma | n2=en:capillary hemangioma (forehead) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:capillary hemangioma (in 1 patient) n1=Xeroderma | n2=en:capillary hemangioma (in 1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:capillary malformations, small, multiple, diffuse n1=Xeroderma | n2=en:capillary malformations, small, multiple, diffuse | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:carbuncle/furuncle n1=Xeroderma | n2=en:carbuncle/furuncle | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cavernous hemangioma n1=Xeroderma | n2=en:cavernous hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cellulitis n1=Xeroderma | n2=en:cellulitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cellulitis over affected area n1=Xeroderma | n2=en:cellulitis over affected area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cellulitis, recurrent (rare) n1=Xeroderma | n2=en:cellulitis, recurrent (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:central atrophic area has a peripheral keratotic ridge n1=Xeroderma | n2=en:central atrophic area has a peripheral keratotic ridge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:centrofacial/mucosal lentigines n1=Xeroderma | n2=en:centrofacial/mucosal lentigines | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cerebriform connective tissue nevus n1=Xeroderma | n2=en:cerebriform connective tissue nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chilblains n1=Xeroderma | n2=en:chilblains | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chin dimples n1=Xeroderma | n2=en:chin dimples | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chronic candidiasis n1=Xeroderma | n2=en:chronic candidiasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chronic disease n1=Xeroderma | n2=en:chronic disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chronic eczematoid rash n1=Xeroderma | n2=en:chronic eczematoid rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chronic folliculitis n1=Xeroderma | n2=en:chronic folliculitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chronic granulomatous nodules (rare) n1=Xeroderma | n2=en:chronic granulomatous nodules (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chronic mucocutaneous candidiasis n1=Xeroderma | n2=en:chronic mucocutaneous candidiasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:chronic skin ulcer n1=Xeroderma | n2=en:chronic skin ulcer | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cicatrization n1=Xeroderma | n2=en:cicatrization | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cigarette-paper scars n1=Xeroderma | n2=en:cigarette-paper scars | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:circumscribed transparent membrane on the scalp vertex may be ulcerated (other areas of the body are rarely involved) n1=Xeroderma | n2=en:circumscribed transparent membrane on the scalp vertex may be ulcerated (other areas of the body are rarely involved) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:clavus formation (rare) n1=Xeroderma | n2=en:clavus formation (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:clear gelatinous pterygia-like plaques of the nasal and temporal perilimbal bulbar conjunctiva n1=Xeroderma | n2=en:clear gelatinous pterygia-like plaques of the nasal and temporal perilimbal bulbar conjunctiva | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cleavage within basal keratinocytes n1=Xeroderma | n2=en:cleavage within basal keratinocytes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:coarse skin n1=Xeroderma | n2=en:coarse skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:coarse, thick skin (especially upper face and scalp) n1=Xeroderma | n2=en:coarse, thick skin (especially upper face and scalp) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:coccygeal skin tags n1=Xeroderma | n2=en:coccygeal skin tags | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cold sweat n1=Xeroderma | n2=en:cold sweat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:collagen-rich connective tissue nevi (dermatofibrosis lenticularis disseminata) n1=Xeroderma | n2=en:collagen-rich connective tissue nevi (dermatofibrosis lenticularis disseminata) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:collodion membrane at birth n1=Xeroderma | n2=en:collodion membrane at birth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:collodion membrane at birth (1 patient) n1=Xeroderma | n2=en:collodion membrane at birth (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:collodion membrane at birth (in most patients) n1=Xeroderma | n2=en:collodion membrane at birth (in most patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:collodion membrane at birth (in some patients) n1=Xeroderma | n2=en:collodion membrane at birth (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:collodion membrane, self-healing (in some patients) n1=Xeroderma | n2=en:collodion membrane, self-healing (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:collodion skin n1=Xeroderma | n2=en:collodion skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:comedo n1=Xeroderma | n2=en:comedo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:concomitant disease aggravated n1=Xeroderma | n2=en:concomitant disease aggravated | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:concomitant disease progression n1=Xeroderma | n2=en:concomitant disease progression | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:condition aggravated n1=Xeroderma | n2=en:condition aggravated | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:confetti-like hypopigmented macules n1=Xeroderma | n2=en:confetti-like hypopigmented macules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital absence of skin in areas n1=Xeroderma | n2=en:congenital absence of skin in areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital absence of skin in some areas (aplasia cutis) n1=Xeroderma | n2=en:congenital absence of skin in some areas (aplasia cutis) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital absence of skin on some areas (aplasia cutis) n1=Xeroderma | n2=en:congenital absence of skin on some areas (aplasia cutis) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital erythrokeratodermia n1=Xeroderma | n2=en:congenital erythrokeratodermia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital ichthyosis n1=Xeroderma | n2=en:congenital ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital localized absence of skin n1=Xeroderma | n2=en:congenital localized absence of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital or acquired anatomic abnormality n1=Xeroderma | n2=en:congenital or acquired anatomic abnormality | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital palmoplantar keratosis n1=Xeroderma | n2=en:congenital palmoplantar keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital poikiloderma on face and exposed skin n1=Xeroderma | n2=en:congenital poikiloderma on face and exposed skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital skin disorder n1=Xeroderma | n2=en:congenital skin disorder | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:congenital symmetrical palmoplantar keratosis n1=Xeroderma | n2=en:congenital symmetrical palmoplantar keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:connective tissue dysplasia n1=Xeroderma | n2=en:connective tissue dysplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:connective tissue nevus n1=Xeroderma | n2=en:connective tissue nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:contact dermatitis and other eczema n1=Xeroderma | n2=en:contact dermatitis and other eczema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:corns and callus n1=Xeroderma | n2=en:corns and callus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:creamy white skin n1=Xeroderma | n2=en:creamy white skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:critical illness n1=Xeroderma | n2=en:critical illness | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:crusting erythematous dermatitis n1=Xeroderma | n2=en:crusting erythematous dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:crying n1=Xeroderma | n2=en:crying | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous 0.5 to 1.0 cm bluish and flesh-colored papules (rarely reported) n1=Xeroderma | n2=en:cutaneous 0.5 to 1.0 cm bluish and flesh-colored papules (rarely reported) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous albinism, tyrosinase-positive n1=Xeroderma | n2=en:cutaneous albinism, tyrosinase-positive | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous and mucosal skin tags n1=Xeroderma | n2=en:cutaneous and mucosal skin tags | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous candidiasis n1=Xeroderma | n2=en:cutaneous candidiasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous capillary malformation n1=Xeroderma | n2=en:cutaneous capillary malformation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous dimples (knees, elbows, shoulders) n1=Xeroderma | n2=en:cutaneous dimples (knees, elbows, shoulders) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous dimpling over bowed tibia n1=Xeroderma | n2=en:cutaneous dimpling over bowed tibia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous folliculitis n1=Xeroderma | n2=en:cutaneous folliculitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous hyperpigmentation (in some patients) n1=Xeroderma | n2=en:cutaneous hyperpigmentation (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous infections (staphylococcus aureus, herpes simplex) n1=Xeroderma | n2=en:cutaneous infections (staphylococcus aureus, herpes simplex) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous laxity (rare) n1=Xeroderma | n2=en:cutaneous laxity (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous leiomyomata (heterozygote carriers) n1=Xeroderma | n2=en:cutaneous leiomyomata (heterozygote carriers) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous leiomyosarcoma (rare) n1=Xeroderma | n2=en:cutaneous leiomyosarcoma (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous lichen amyloidosis n1=Xeroderma | n2=en:cutaneous lichen amyloidosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous mastocytosis n1=Xeroderma | n2=en:cutaneous mastocytosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous melanoma n1=Xeroderma | n2=en:cutaneous melanoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous nevi flammei (limbs) n1=Xeroderma | n2=en:cutaneous nevi flammei (limbs) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous piloleiomyomas (may be single or multiple) n1=Xeroderma | n2=en:cutaneous piloleiomyomas (may be single or multiple) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous syndactyly n1=Xeroderma | n2=en:cutaneous syndactyly | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous syndactyly (less common) n1=Xeroderma | n2=en:cutaneous syndactyly (less common) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous telangiectases of face, upper chest, upper mid-back, upper extremities, and hands n1=Xeroderma | n2=en:cutaneous telangiectases of face, upper chest, upper mid-back, upper extremities, and hands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous vascular malformation n1=Xeroderma | n2=en:cutaneous vascular malformation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutaneous vasculitis n1=Xeroderma | n2=en:cutaneous vasculitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis aplasia, occipital n1=Xeroderma | n2=en:cutis aplasia, occipital | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis gyrata n1=Xeroderma | n2=en:cutis gyrata | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis laxa n1=Xeroderma | n2=en:cutis laxa | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis laxa (especially hands and feet) n1=Xeroderma | n2=en:cutis laxa (especially hands and feet) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis laxa (infancy) n1=Xeroderma | n2=en:cutis laxa (infancy) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis laxa, hands and feet (present at birth) n1=Xeroderma | n2=en:cutis laxa, hands and feet (present at birth) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis marmorata n1=Xeroderma | n2=en:cutis marmorata | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis marmorata (in some patients) n1=Xeroderma | n2=en:cutis marmorata (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis marmorata (in some) n1=Xeroderma | n2=en:cutis marmorata (in some) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis marmorata (rare) n1=Xeroderma | n2=en:cutis marmorata (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis marmorata telangiectatica congenita n1=Xeroderma | n2=en:cutis marmorata telangiectatica congenita | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cutis verticis gyrata (onset age 40) n1=Xeroderma | n2=en:cutis verticis gyrata (onset age 40) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cyanosis n1=Xeroderma | n2=en:cyanosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cyanosis (25%) n1=Xeroderma | n2=en:cyanosis (25%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cyanosis due to methemoglobinemia n1=Xeroderma | n2=en:cyanosis due to methemoglobinemia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cyanosis during episodes n1=Xeroderma | n2=en:cyanosis during episodes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cylindromas usually occur on the scalp may coalesce into large 'turban tumors' n1=Xeroderma | n2=en:cylindromas usually occur on the scalp may coalesce into large 'turban tumors' | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cylindromas, multiple (face, trunk and extremities) n1=Xeroderma | n2=en:cylindromas, multiple (face, trunk and extremities) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cylindromas, multiple (usually occur on the scalp, but may also occur on the face, trunk, and extremities) n1=Xeroderma | n2=en:cylindromas, multiple (usually occur on the scalp, but may also occur on the face, trunk, and extremities) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cyst occur most often on the scalp (89%) n1=Xeroderma | n2=en:cyst occur most often on the scalp (89%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts are firm and smooth n1=Xeroderma | n2=en:cysts are firm and smooth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts may be multiple (70%) n1=Xeroderma | n2=en:cysts may be multiple (70%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts may be solitary (30%) n1=Xeroderma | n2=en:cysts may be solitary (30%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts may become infected (15%) n1=Xeroderma | n2=en:cysts may become infected (15%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts may disappear on their own (10%) n1=Xeroderma | n2=en:cysts may disappear on their own (10%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts may gradually increase in size n1=Xeroderma | n2=en:cysts may gradually increase in size | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts occur less commonly on any part of the body where hair grows n1=Xeroderma | n2=en:cysts occur less commonly on any part of the body where hair grows | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:cysts over wrist and ankle joints n1=Xeroderma | n2=en:cysts over wrist and ankle joints | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:darier disease n1=Xeroderma | n2=en:darier disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dark circles under eyes n1=Xeroderma | n2=en:dark circles under eyes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dark pigmentation of knees and dorsum of hands and feet n1=Xeroderma | n2=en:dark pigmentation of knees and dorsum of hands and feet | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dark skin pigmentation n1=Xeroderma | n2=en:dark skin pigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:darkly pigmented skin n1=Xeroderma | n2=en:darkly pigmented skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:de- or hypo-pigmented macules (less common) n1=Xeroderma | n2=en:de- or hypo-pigmented macules (less common) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased exercise tolerance n1=Xeroderma | n2=en:decreased exercise tolerance | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased flexion creases n1=Xeroderma | n2=en:decreased flexion creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased histidase activity n1=Xeroderma | n2=en:decreased histidase activity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased intraepithelial nerve fiber density n1=Xeroderma | n2=en:decreased intraepithelial nerve fiber density | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased number of sweat pores n1=Xeroderma | n2=en:decreased number of sweat pores | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased palmar creases n1=Xeroderma | n2=en:decreased palmar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased sweating due to autonomic dysfunction n1=Xeroderma | n2=en:decreased sweating due to autonomic dysfunction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased sweating of palms and soles n1=Xeroderma | n2=en:decreased sweating of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:decreased urocanic acid in stratum corneum n1=Xeroderma | n2=en:decreased urocanic acid in stratum corneum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deep fissures of skin creases n1=Xeroderma | n2=en:deep fissures of skin creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deep foot creases n1=Xeroderma | n2=en:deep foot creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deep palmar crease n1=Xeroderma | n2=en:deep palmar crease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deep plantar creases n1=Xeroderma | n2=en:deep plantar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deep skin creases in toes n1=Xeroderma | n2=en:deep skin creases in toes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deep skin ulcers n1=Xeroderma | n2=en:deep skin ulcers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deficiency of the interleukin-36 receptor antagonist n1=Xeroderma | n2=en:deficiency of the interleukin-36 receptor antagonist | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:degeneration of basal epidermal cells n1=Xeroderma | n2=en:degeneration of basal epidermal cells | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dependent acrocyanosis n1=Xeroderma | n2=en:dependent acrocyanosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:depigmentation/hyperpigmentation n1=Xeroderma | n2=en:depigmentation/hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:depigmented spots n1=Xeroderma | n2=en:depigmented spots | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:deposition of calcium phosphate crystals in skin and subcutaneous tissues n1=Xeroderma | n2=en:deposition of calcium phosphate crystals in skin and subcutaneous tissues | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:derived from hair matrix cells n1=Xeroderma | n2=en:derived from hair matrix cells | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermal contractures (late complication) n1=Xeroderma | n2=en:dermal contractures (late complication) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermal melanocytosis n1=Xeroderma | n2=en:dermal melanocytosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermal ossification (osteoma cutis) n1=Xeroderma | n2=en:dermal ossification (osteoma cutis) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermal translucency n1=Xeroderma | n2=en:dermal translucency | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis n1=Xeroderma | n2=en:dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis (chronic or chronically relapsing, major feature) n1=Xeroderma | n2=en:dermatitis (chronic or chronically relapsing, major feature) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis (in some patients) n1=Xeroderma | n2=en:dermatitis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis acidemica n1=Xeroderma | n2=en:dermatitis acidemica | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis herpetiformis n1=Xeroderma | n2=en:dermatitis herpetiformis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis ichthyosiform n1=Xeroderma | n2=en:dermatitis ichthyosiform | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis, atopic n1=Xeroderma | n2=en:dermatitis, atopic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis, infectious, due to immunodeficiency n1=Xeroderma | n2=en:dermatitis, infectious, due to immunodeficiency | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis, infectious, due to immunodeficiency impetigo n1=Xeroderma | n2=en:dermatitis, infectious, due to immunodeficiency impetigo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatitis, symmetric pattern n1=Xeroderma | n2=en:dermatitis, symmetric pattern | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatographism (dermatographic urticaria) n1=Xeroderma | n2=en:dermatographism (dermatographic urticaria) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatomycoses n1=Xeroderma | n2=en:dermatomycoses | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatophytosis n1=Xeroderma | n2=en:dermatophytosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatophytosis, chronic deep dermatophytosis (in some patients) n1=Xeroderma | n2=en:dermatophytosis, chronic deep dermatophytosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatoses, general and nec n1=Xeroderma | n2=en:dermatoses, general and nec | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermatosis steroid-induced n1=Xeroderma | n2=en:dermatosis steroid-induced | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermis n1=Xeroderma | n2=en:dermis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermis thinning n1=Xeroderma | n2=en:dermis thinning | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dermo-epidermal junction n1=Xeroderma | n2=en:dermo-epidermal junction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:desquamation n1=Xeroderma | n2=en:desquamation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:desquamation of skin soon after birth n1=Xeroderma | n2=en:desquamation of skin soon after birth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:developmental delay n1=Xeroderma | n2=en:developmental delay | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:developmental regression n1=Xeroderma | n2=en:developmental regression | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diaper dermatitis n1=Xeroderma | n2=en:diaper dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diaphoresis n1=Xeroderma | n2=en:diaphoresis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diaphoresis (with pheochromocytoma) n1=Xeroderma | n2=en:diaphoresis (with pheochromocytoma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:difficulty standing n1=Xeroderma | n2=en:difficulty standing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diffuse erythematous maculopapular rash n1=Xeroderma | n2=en:diffuse erythematous maculopapular rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diffuse hyperkeratosis (in some patients) n1=Xeroderma | n2=en:diffuse hyperkeratosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diffuse pigmentary skin mottling, mild, on trunk and proximal limbs n1=Xeroderma | n2=en:diffuse pigmentary skin mottling, mild, on trunk and proximal limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diffuse skin atrophy (especially dorsa of hands and feet) n1=Xeroderma | n2=en:diffuse skin atrophy (especially dorsa of hands and feet) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diffuse skin wrinkling (especially dorsa of hands and feet) n1=Xeroderma | n2=en:diffuse skin wrinkling (especially dorsa of hands and feet) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diffuse telangiectasis n1=Xeroderma | n2=en:diffuse telangiectasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diffuse yellow-orange non-epidermolytic hyperkeratosis on palms and soles (palmoplantar keratoderma) n1=Xeroderma | n2=en:diffuse yellow-orange non-epidermolytic hyperkeratosis on palms and soles (palmoplantar keratoderma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:digestive system disorder n1=Xeroderma | n2=en:digestive system disorder | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dilated scalp veins radiating from periphery of scalp defect n1=Xeroderma | n2=en:dilated scalp veins radiating from periphery of scalp defect | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:diminished sweating n1=Xeroderma | n2=en:diminished sweating | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dimple overlying knee n1=Xeroderma | n2=en:dimple overlying knee | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dimples (chin, buttocks) n1=Xeroderma | n2=en:dimples (chin, buttocks) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dimples (medial and lateral aspect of lower leg) n1=Xeroderma | n2=en:dimples (medial and lateral aspect of lower leg) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dimples (over bowed limbs) n1=Xeroderma | n2=en:dimples (over bowed limbs) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dimples over large joints n1=Xeroderma | n2=en:dimples over large joints | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dimples overlying contractures n1=Xeroderma | n2=en:dimples overlying contractures | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:discoid lupus erythematosus n1=Xeroderma | n2=en:discoid lupus erythematosus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:discoid lupus in carriers or adults with mild disease n1=Xeroderma | n2=en:discoid lupus in carriers or adults with mild disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:discoid rash n1=Xeroderma | n2=en:discoid rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:discrete 2 to 5-mm hyper- and hypopigmented macules n1=Xeroderma | n2=en:discrete 2 to 5-mm hyper- and hypopigmented macules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:disease complication n1=Xeroderma | n2=en:disease complication | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:disease prodromal stage n1=Xeroderma | n2=en:disease prodromal stage | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:disease progression n1=Xeroderma | n2=en:disease progression | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:disease recurrence n1=Xeroderma | n2=en:disease recurrence | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:distal painless ulcers n1=Xeroderma | n2=en:distal painless ulcers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:distinct odor of palms and soles n1=Xeroderma | n2=en:distinct odor of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:distorted triradii of palmar skin n1=Xeroderma | n2=en:distorted triradii of palmar skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:disuse syndrome n1=Xeroderma | n2=en:disuse syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dorsal hand wrinkling n1=Xeroderma | n2=en:dorsal hand wrinkling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:doughy or puffy skin (in some patients) n1=Xeroderma | n2=en:doughy or puffy skin (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:doughy skin n1=Xeroderma | n2=en:doughy skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:draining sinuses (late complication) n1=Xeroderma | n2=en:draining sinuses (late complication) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry palmar skin n1=Xeroderma | n2=en:dry palmar skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry skin n1=Xeroderma | n2=en:dry skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry skin aggravated n1=Xeroderma | n2=en:dry skin aggravated | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry, bumpy skin n1=Xeroderma | n2=en:dry, bumpy skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry, rough skin n1=Xeroderma | n2=en:dry, rough skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry, scaly skin n1=Xeroderma | n2=en:dry, scaly skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry, stiff skin n1=Xeroderma | n2=en:dry, stiff skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dry, thick skin n1=Xeroderma | n2=en:dry, thick skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dyshidrosis [pompholyx] n1=Xeroderma | n2=en:dyshidrosis [pompholyx] | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:dysseborrheic dermatitis n1=Xeroderma | n2=en:dysseborrheic dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ear skin n1=Xeroderma | n2=en:ear skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:early freckle-like lesions in exposed areas n1=Xeroderma | n2=en:early freckle-like lesions in exposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:early onset skin cancer (basal cell, squamous cell and malignant melanoma) n1=Xeroderma | n2=en:early onset skin cancer (basal cell, squamous cell and malignant melanoma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:easy bruising n1=Xeroderma | n2=en:easy bruising | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:easy bruising (1 family) n1=Xeroderma | n2=en:easy bruising (1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:easy bruising (in some patients) n1=Xeroderma | n2=en:easy bruising (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ecchymoses common n1=Xeroderma | n2=en:ecchymoses common | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ecchymosis n1=Xeroderma | n2=en:ecchymosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ectodermal dysplasia n1=Xeroderma | n2=en:ectodermal dysplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ectodermal dystrophy n1=Xeroderma | n2=en:ectodermal dystrophy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ectodermal symptoms n1=Xeroderma | n2=en:ectodermal symptoms | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema n1=Xeroderma | n2=en:eczema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema (8 of 23) n1=Xeroderma | n2=en:eczema (8 of 23) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema (face and flexural areas) n1=Xeroderma | n2=en:eczema (face and flexural areas) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema (in 1 patient) n1=Xeroderma | n2=en:eczema (in 1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema (in some patients) n1=Xeroderma | n2=en:eczema (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema (perifollicular accentuation) n1=Xeroderma | n2=en:eczema (perifollicular accentuation) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema (rare) n1=Xeroderma | n2=en:eczema (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema-like lesions (in some patients) n1=Xeroderma | n2=en:eczema-like lesions (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczema, severe n1=Xeroderma | n2=en:eczema, severe | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eczemetous abnormalities n1=Xeroderma | n2=en:eczemetous abnormalities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:edema n1=Xeroderma | n2=en:edema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:edema of dorsum of hands and feet n1=Xeroderma | n2=en:edema of dorsum of hands and feet | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:edema, generalized n1=Xeroderma | n2=en:edema, generalized | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:edema, generalized perinatal (in some patients) n1=Xeroderma | n2=en:edema, generalized perinatal (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:effusion n1=Xeroderma | n2=en:effusion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:elastin-rich connective tissue nevi (elastoma) n1=Xeroderma | n2=en:elastin-rich connective tissue nevi (elastoma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:elastosis perforans serpiginosa n1=Xeroderma | n2=en:elastosis perforans serpiginosa | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:elbow dimples n1=Xeroderma | n2=en:elbow dimples | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:enhanced secondary hyperalgesia and flare response on mustard oil application n1=Xeroderma | n2=en:enhanced secondary hyperalgesia and flare response on mustard oil application | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:entire skin n1=Xeroderma | n2=en:entire skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermal derivative n1=Xeroderma | n2=en:epidermal derivative | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermal hyperkeratosis n1=Xeroderma | n2=en:epidermal hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermal inclusion cyst n1=Xeroderma | n2=en:epidermal inclusion cyst | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermal nevus n1=Xeroderma | n2=en:epidermal nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermal ridges absent from palms and soles n1=Xeroderma | n2=en:epidermal ridges absent from palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermis n1=Xeroderma | n2=en:epidermis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermoid inclusion cysts n1=Xeroderma | n2=en:epidermoid inclusion cysts | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermolysis bullosa dystrophica n1=Xeroderma | n2=en:epidermolysis bullosa dystrophica | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermolysis bullosa simplex n1=Xeroderma | n2=en:epidermolysis bullosa simplex | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermolytic hyperkeratosis, mild n1=Xeroderma | n2=en:epidermolytic hyperkeratosis, mild | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:epidermolytic palmoplantar keratoderma n1=Xeroderma | n2=en:epidermolytic palmoplantar keratoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:episodic cold-triggered erythrocyanosis of toes and fingers n1=Xeroderma | n2=en:episodic cold-triggered erythrocyanosis of toes and fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:episodic hyperhidrosis n1=Xeroderma | n2=en:episodic hyperhidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:episodic urticaria n1=Xeroderma | n2=en:episodic urticaria | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erdheim-chester disease n1=Xeroderma | n2=en:erdheim-chester disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erosion n1=Xeroderma | n2=en:erosion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erosion, generalized n1=Xeroderma | n2=en:erosion, generalized | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eruptive xanthoma n1=Xeroderma | n2=en:eruptive xanthoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erysipelas n1=Xeroderma | n2=en:erysipelas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erysipelas (in some patients) n1=Xeroderma | n2=en:erysipelas (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema n1=Xeroderma | n2=en:erythema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema in affected areas n1=Xeroderma | n2=en:erythema in affected areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema marginatum n1=Xeroderma | n2=en:erythema marginatum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema nodosum n1=Xeroderma | n2=en:erythema nodosum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema, blisters, pustules (cyclical, explosive episodes) n1=Xeroderma | n2=en:erythema, blisters, pustules (cyclical, explosive episodes) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema, cold-induced n1=Xeroderma | n2=en:erythema, cold-induced | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema, mild to moderate (in some patients) n1=Xeroderma | n2=en:erythema, mild to moderate (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythema, residual painless n1=Xeroderma | n2=en:erythema, residual painless | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous blotching, episodic n1=Xeroderma | n2=en:erythematous blotching, episodic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous ichthyotic skin with reticulate pattern n1=Xeroderma | n2=en:erythematous ichthyotic skin with reticulate pattern | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous malar rash n1=Xeroderma | n2=en:erythematous malar rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous nodular skin lesions n1=Xeroderma | n2=en:erythematous nodular skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous palmoplantar hyperkeratosis, progressive extending onto dorsum of hands and achilles tendon area n1=Xeroderma | n2=en:erythematous palmoplantar hyperkeratosis, progressive extending onto dorsum of hands and achilles tendon area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous papular skin eruption (infancy) n1=Xeroderma | n2=en:erythematous papular skin eruption (infancy) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous plaque n1=Xeroderma | n2=en:erythematous plaque | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous rash (in some patients) n1=Xeroderma | n2=en:erythematous rash (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous skin blotching n1=Xeroderma | n2=en:erythematous skin blotching | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous skin lesions in infancy n1=Xeroderma | n2=en:erythematous skin lesions in infancy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous squamous skin lesions n1=Xeroderma | n2=en:erythematous squamous skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythematous, irregular netlike pattern of vessels n1=Xeroderma | n2=en:erythematous, irregular netlike pattern of vessels | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythroderma n1=Xeroderma | n2=en:erythroderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythroderma (in some patients) n1=Xeroderma | n2=en:erythroderma (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythroderma, generalized congenital n1=Xeroderma | n2=en:erythroderma, generalized congenital | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythroderma, patchy, on cheeks and chin (1/4 patients) n1=Xeroderma | n2=en:erythroderma, patchy, on cheeks and chin (1/4 patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythroderma, psoriasiform n1=Xeroderma | n2=en:erythroderma, psoriasiform | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:erythrokeratodermia n1=Xeroderma | n2=en:erythrokeratodermia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eschar formation n1=Xeroderma | n2=en:eschar formation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:excessive salt in sweat n1=Xeroderma | n2=en:excessive salt in sweat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:excessive skin folds n1=Xeroderma | n2=en:excessive skin folds | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:excessive skin wrinkling of palms and soles (in one patient) n1=Xeroderma | n2=en:excessive skin wrinkling of palms and soles (in one patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:excessive skin wrinkling on dorsum of hands and fingers n1=Xeroderma | n2=en:excessive skin wrinkling on dorsum of hands and fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:exercise tolerance increased n1=Xeroderma | n2=en:exercise tolerance increased | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:exophytic, red lesion n1=Xeroderma | n2=en:exophytic, red lesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:extensive cutaneous involvement rarely occurs n1=Xeroderma | n2=en:extensive cutaneous involvement rarely occurs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:external ear n1=Xeroderma | n2=en:external ear | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:extravasation n1=Xeroderma | n2=en:extravasation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:extreme skin fragility n1=Xeroderma | n2=en:extreme skin fragility | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:extrusion of calcium deposits ('perforating pxe') n1=Xeroderma | n2=en:extrusion of calcium deposits ('perforating pxe') | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eyelid n1=Xeroderma | n2=en:eyelid | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:eyelid margin cysts (apocrine hidrocystoma) n1=Xeroderma | n2=en:eyelid margin cysts (apocrine hidrocystoma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial angiofibroma (adenoma sebaceum) n1=Xeroderma | n2=en:facial angiofibroma (adenoma sebaceum) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial capillary hemangioma n1=Xeroderma | n2=en:facial capillary hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial erythema n1=Xeroderma | n2=en:facial erythema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial hemangioma n1=Xeroderma | n2=en:facial hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial hyperpigmentation n1=Xeroderma | n2=en:facial hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial midline hemangioma n1=Xeroderma | n2=en:facial midline hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial milia n1=Xeroderma | n2=en:facial milia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial milia tend to disappear in adulthood n1=Xeroderma | n2=en:facial milia tend to disappear in adulthood | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial milia, congenital, especially on chin n1=Xeroderma | n2=en:facial milia, congenital, especially on chin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial or extensor involvement in infants and children (major feature) n1=Xeroderma | n2=en:facial or extensor involvement in infants and children (major feature) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial pallor n1=Xeroderma | n2=en:facial pallor | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial telangiectasia in butterfly midface distribution (exacerbated by sun) n1=Xeroderma | n2=en:facial telangiectasia in butterfly midface distribution (exacerbated by sun) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial trichilemmomas n1=Xeroderma | n2=en:facial trichilemmomas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:facial xanthomatous eruptions (rare) n1=Xeroderma | n2=en:facial xanthomatous eruptions (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fades in adolescence n1=Xeroderma | n2=en:fades in adolescence | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fair skin n1=Xeroderma | n2=en:fair skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:familial progressive hyperpigmentation and hypopigmentation n1=Xeroderma | n2=en:familial progressive hyperpigmentation and hypopigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fat pad n1=Xeroderma | n2=en:fat pad | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fat tissue decreased n1=Xeroderma | n2=en:fat tissue decreased | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fear of cancer of skin n1=Xeroderma | n2=en:fear of cancer of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fear of having other skin disease n1=Xeroderma | n2=en:fear of having other skin disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fetal growth retardation n1=Xeroderma | n2=en:fetal growth retardation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fetal pads of digits n1=Xeroderma | n2=en:fetal pads of digits | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fibrofolliculoma n1=Xeroderma | n2=en:fibrofolliculoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fibroma n1=Xeroderma | n2=en:fibroma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fibrosis over affected area n1=Xeroderma | n2=en:fibrosis over affected area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fibrous nodule n1=Xeroderma | n2=en:fibrous nodule | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fibrous skin tumor of tuberous sclerosis n1=Xeroderma | n2=en:fibrous skin tumor of tuberous sclerosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine erythrodermic scales, generalized n1=Xeroderma | n2=en:fine erythrodermic scales, generalized | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine greyish-white scales n1=Xeroderma | n2=en:fine greyish-white scales | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine white or greyish-white scales n1=Xeroderma | n2=en:fine white or greyish-white scales | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine white or light brown scales on scalp, face, trunk, and limbs n1=Xeroderma | n2=en:fine white or light brown scales on scalp, face, trunk, and limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine white scales n1=Xeroderma | n2=en:fine white scales | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine whitish scales (rare) n1=Xeroderma | n2=en:fine whitish scales (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine whitish scales over entire surface of skin n1=Xeroderma | n2=en:fine whitish scales over entire surface of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine whitish scaling on face and trunk n1=Xeroderma | n2=en:fine whitish scaling on face and trunk | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fine, reticulate skin pigmentation (trunk, palm, and soles) n1=Xeroderma | n2=en:fine, reticulate skin pigmentation (trunk, palm, and soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:finely wrinkled palms n1=Xeroderma | n2=en:finely wrinkled palms | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:finger subcutaneous nodule n1=Xeroderma | n2=en:finger subcutaneous nodule | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fingerprints, absence of n1=Xeroderma | n2=en:fingerprints, absence of | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fissures of soles (in some patients) n1=Xeroderma | n2=en:fissures of soles (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fissuring of palms and/or soles in hot or cold weather n1=Xeroderma | n2=en:fissuring of palms and/or soles in hot or cold weather | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fistula discharge n1=Xeroderma | n2=en:fistula discharge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fistula formation (late complication) n1=Xeroderma | n2=en:fistula formation (late complication) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fistula, enterocutaneous n1=Xeroderma | n2=en:fistula, enterocutaneous | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fixed eruption n1=Xeroderma | n2=en:fixed eruption | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:flares of erythema, scaling, and pustules n1=Xeroderma | n2=en:flares of erythema, scaling, and pustules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:flexion contractures of hands due to severe hyperkeratosis n1=Xeroderma | n2=en:flexion contractures of hands due to severe hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:flexural acanthosis nigricans (females, childhood-early adolescence) n1=Xeroderma | n2=en:flexural acanthosis nigricans (females, childhood-early adolescence) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:flexural lichenification in adults (major feature) n1=Xeroderma | n2=en:flexural lichenification in adults (major feature) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:flexural skin n1=Xeroderma | n2=en:flexural skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:florid red complexion (finding) n1=Xeroderma | n2=en:florid red complexion (finding) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:flushing n1=Xeroderma | n2=en:flushing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:flushing attacks n1=Xeroderma | n2=en:flushing attacks | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:foaming at mouth n1=Xeroderma | n2=en:foaming at mouth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:focal dermal aplasia/hypoplasia n1=Xeroderma | n2=en:focal dermal aplasia/hypoplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:focal friction-related palmoplantar hyperkeratosis n1=Xeroderma | n2=en:focal friction-related palmoplantar hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:focal hyperkeratosis (in some patients) n1=Xeroderma | n2=en:focal hyperkeratosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:focal keratoderma of soles (in some patients) n1=Xeroderma | n2=en:focal keratoderma of soles (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:focal scalp defects with alopecia n1=Xeroderma | n2=en:focal scalp defects with alopecia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:focal skin hypoplasia in face n1=Xeroderma | n2=en:focal skin hypoplasia in face | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular atrophoderma n1=Xeroderma | n2=en:follicular atrophoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular atrophoderma (in some patients) n1=Xeroderma | n2=en:follicular atrophoderma (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows and knees n1=Xeroderma | n2=en:follicular atrophoderma affecting the dorsa of the hands and feet, the face, and extensor surfaces of the elbows and knees | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular hyperkeratosis n1=Xeroderma | n2=en:follicular hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular hyperkeratosis (trunk and limbs) n1=Xeroderma | n2=en:follicular hyperkeratosis (trunk and limbs) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular hyperkeratosis of occipital scalp, nape of neck, and extensor surfaces of upper limbs n1=Xeroderma | n2=en:follicular hyperkeratosis of occipital scalp, nape of neck, and extensor surfaces of upper limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular hyperkeratotic papules n1=Xeroderma | n2=en:follicular hyperkeratotic papules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular keratosis, generalized (in some patients) n1=Xeroderma | n2=en:follicular keratosis, generalized (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follicular papule n1=Xeroderma | n2=en:follicular papule | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:folliculitis n1=Xeroderma | n2=en:folliculitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:folliculitis (back, axilla, pubic region) n1=Xeroderma | n2=en:folliculitis (back, axilla, pubic region) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:folliculitis of the scalp, trunk, and extensor surfaces of the extremities n1=Xeroderma | n2=en:folliculitis of the scalp, trunk, and extensor surfaces of the extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:follows blaschko's lines n1=Xeroderma | n2=en:follows blaschko's lines | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:foot callus n1=Xeroderma | n2=en:foot callus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:forehead hyperpigmentation n1=Xeroderma | n2=en:forehead hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fragile skin n1=Xeroderma | n2=en:fragile skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fragile skin with atrophic scarring n1=Xeroderma | n2=en:fragile skin with atrophic scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:fragility with blistering (neonatal onset) n1=Xeroderma | n2=en:fragility with blistering (neonatal onset) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:freckled skin (in some less dark-skinned individuals) n1=Xeroderma | n2=en:freckled skin (in some less dark-skinned individuals) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:freckles n1=Xeroderma | n2=en:freckles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:freckles in sun-exposed areas n1=Xeroderma | n2=en:freckles in sun-exposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:freckling may or may not be present n1=Xeroderma | n2=en:freckling may or may not be present | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:frequent bleeding may occur with trauma n1=Xeroderma | n2=en:frequent bleeding may occur with trauma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:frequent staphylococcus aureus infections n1=Xeroderma | n2=en:frequent staphylococcus aureus infections | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:frontal cutaneous lipoma n1=Xeroderma | n2=en:frontal cutaneous lipoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:frontal hirsutism n1=Xeroderma | n2=en:frontal hirsutism | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:frostbitten hands n1=Xeroderma | n2=en:frostbitten hands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:furrowed facial skin n1=Xeroderma | n2=en:furrowed facial skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:general physical health deterioration n1=Xeroderma | n2=en:general physical health deterioration | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:general signs and symptoms nec n1=Xeroderma | n2=en:general signs and symptoms nec | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:general symptom n1=Xeroderma | n2=en:general symptom | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized bronze hyperpigmentation (present at birth) n1=Xeroderma | n2=en:generalized bronze hyperpigmentation (present at birth) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized bruising tendency n1=Xeroderma | n2=en:generalized bruising tendency | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized darkening of the skin n1=Xeroderma | n2=en:generalized darkening of the skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized dry skin with fine scaling but without erythema or blisters. (sparing of face) n1=Xeroderma | n2=en:generalized dry skin with fine scaling but without erythema or blisters. (sparing of face) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized erythema (inflammatory type b) n1=Xeroderma | n2=en:generalized erythema (inflammatory type b) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized hyperkeratosis n1=Xeroderma | n2=en:generalized hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized hypopigmentation n1=Xeroderma | n2=en:generalized hypopigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized ichthyosis n1=Xeroderma | n2=en:generalized ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized rash n1=Xeroderma | n2=en:generalized rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized skin wrinkling n1=Xeroderma | n2=en:generalized skin wrinkling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:generalized swelling/papules/lumps/masses n1=Xeroderma | n2=en:generalized swelling/papules/lumps/masses | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:giant pigmented hairy nevus, often in lumbosacral distribution hair may not be present n1=Xeroderma | n2=en:giant pigmented hairy nevus, often in lumbosacral distribution hair may not be present | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:giant pigmented nevi, often in lumbosacral region n1=Xeroderma | n2=en:giant pigmented nevi, often in lumbosacral region | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:gilbert syndrome n1=Xeroderma | n2=en:gilbert syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:gingival hyperkeratosis n1=Xeroderma | n2=en:gingival hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:glabellar hemangioma n1=Xeroderma | n2=en:glabellar hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:glabrous skin n1=Xeroderma | n2=en:glabrous skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:glassy eyes n1=Xeroderma | n2=en:glassy eyes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:granular layer hyperplasia n1=Xeroderma | n2=en:granular layer hyperplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:granulomatous dermatitis n1=Xeroderma | n2=en:granulomatous dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:granulomatous dermatitis (in some patients) n1=Xeroderma | n2=en:granulomatous dermatitis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hair and hair follicle diseases n1=Xeroderma | n2=en:hair and hair follicle diseases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hair follicle disorder n1=Xeroderma | n2=en:hair follicle disorder | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hallermann syndrome n1=Xeroderma | n2=en:hallermann syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hand dermatitis (non-allergic, irritant) n1=Xeroderma | n2=en:hand dermatitis (non-allergic, irritant) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hard scaly skin n1=Xeroderma | n2=en:hard scaly skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:harlequin ichthyosis n1=Xeroderma | n2=en:harlequin ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:head skin n1=Xeroderma | n2=en:head skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:healed areas are atrophic and hypopigmented n1=Xeroderma | n2=en:healed areas are atrophic and hypopigmented | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemangioma n1=Xeroderma | n2=en:hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemangioma (neck and forehead) n1=Xeroderma | n2=en:hemangioma (neck and forehead) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemangiomas (facial, glabellar) n1=Xeroderma | n2=en:hemangiomas (facial, glabellar) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemangiomas and lymphangiomas of any site n1=Xeroderma | n2=en:hemangiomas and lymphangiomas of any site | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemangiomata in at least first branch (ophthalmic) of trigeminal nerve distribution, unilateral, occasionally bilateral n1=Xeroderma | n2=en:hemangiomata in at least first branch (ophthalmic) of trigeminal nerve distribution, unilateral, occasionally bilateral | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemangiomata, especially thorax and upper abdomen n1=Xeroderma | n2=en:hemangiomata, especially thorax and upper abdomen | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemangiomatous branchial clefts (extend along sternocleidomastoid muscle) n1=Xeroderma | n2=en:hemangiomatous branchial clefts (extend along sternocleidomastoid muscle) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemorrhagic blisters n1=Xeroderma | n2=en:hemorrhagic blisters | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hemorrhagic palmar and plantar macules (uncommon) n1=Xeroderma | n2=en:hemorrhagic palmar and plantar macules (uncommon) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:herpes simplex infections n1=Xeroderma | n2=en:herpes simplex infections | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:herpes zoster n1=Xeroderma | n2=en:herpes zoster | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hidradenitis suppurativa (rare) n1=Xeroderma | n2=en:hidradenitis suppurativa (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hidrocystoma n1=Xeroderma | n2=en:hidrocystoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:high sweat electrolyte n1=Xeroderma | n2=en:high sweat electrolyte | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hirsutism n1=Xeroderma | n2=en:hirsutism | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:histology shows 'cannonball' distribution of capillary-sized vessels in the dermis n1=Xeroderma | n2=en:histology shows 'cannonball' distribution of capillary-sized vessels in the dermis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:histology shows exterior zone of densely packed, small basophilic cells n1=Xeroderma | n2=en:histology shows exterior zone of densely packed, small basophilic cells | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:honeycomb keratoderma n1=Xeroderma | n2=en:honeycomb keratoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:honeycomb palmoplantar keratoderma n1=Xeroderma | n2=en:honeycomb palmoplantar keratoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:horny papules (face, leg, buttocks) n1=Xeroderma | n2=en:horny papules (face, leg, buttocks) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hot flashes n1=Xeroderma | n2=en:hot flashes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyaline deposition in dermis n1=Xeroderma | n2=en:hyaline deposition in dermis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperalgesia to pressure n1=Xeroderma | n2=en:hyperalgesia to pressure | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperelasticity (in some patients) n1=Xeroderma | n2=en:hyperelasticity (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperextensible skin n1=Xeroderma | n2=en:hyperextensible skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperextensible skin (in some patients) n1=Xeroderma | n2=en:hyperextensible skin (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperhidrosis n1=Xeroderma | n2=en:hyperhidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperhidrosis (hands and feet) n1=Xeroderma | n2=en:hyperhidrosis (hands and feet) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperhidrosis (in some patients) n1=Xeroderma | n2=en:hyperhidrosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperhidrosis occurs during pain episodes n1=Xeroderma | n2=en:hyperhidrosis occurs during pain episodes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperhidrosis of plantar surface (in some patients) n1=Xeroderma | n2=en:hyperhidrosis of plantar surface (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperhidrosis palmaris et plantaris n1=Xeroderma | n2=en:hyperhidrosis palmaris et plantaris | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis n1=Xeroderma | n2=en:hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis (especially extensor surfaces) n1=Xeroderma | n2=en:hyperkeratosis (especially extensor surfaces) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis (in some patients) n1=Xeroderma | n2=en:hyperkeratosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis (palms, soles, elbows, knees) n1=Xeroderma | n2=en:hyperkeratosis (palms, soles, elbows, knees) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis of pressure sites of palms and soles n1=Xeroderma | n2=en:hyperkeratosis of pressure sites of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis of skin at nipples and umbilicus n1=Xeroderma | n2=en:hyperkeratosis of skin at nipples and umbilicus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis of the palms (seen in recessive form) n1=Xeroderma | n2=en:hyperkeratosis of the palms (seen in recessive form) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis of the palms and soles and esophageal papillomas n1=Xeroderma | n2=en:hyperkeratosis of the palms and soles and esophageal papillomas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis of weight-bearing areas of soles n1=Xeroderma | n2=en:hyperkeratosis of weight-bearing areas of soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis on dorsal surface of fingers and toes (knuckle pads, in some patients) n1=Xeroderma | n2=en:hyperkeratosis on dorsal surface of fingers and toes (knuckle pads, in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis over affected area n1=Xeroderma | n2=en:hyperkeratosis over affected area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis over edematous areas n1=Xeroderma | n2=en:hyperkeratosis over edematous areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis pilaris may occur n1=Xeroderma | n2=en:hyperkeratosis pilaris may occur | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis, focal, on the palms and soles (in adulthood in some) n1=Xeroderma | n2=en:hyperkeratosis, focal, on the palms and soles (in adulthood in some) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratosis, particularly on palms and soles of feet n1=Xeroderma | n2=en:hyperkeratosis, particularly on palms and soles of feet | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic cutaneous vascular lesions n1=Xeroderma | n2=en:hyperkeratotic cutaneous vascular lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic dark-brown papules n1=Xeroderma | n2=en:hyperkeratotic dark-brown papules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic lesions of neck, elbows, knees, groin, genitalia, and buttocks n1=Xeroderma | n2=en:hyperkeratotic lesions of neck, elbows, knees, groin, genitalia, and buttocks | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic papules, dark brown, on neck, chest, and back (in some patients) n1=Xeroderma | n2=en:hyperkeratotic papules, dark brown, on neck, chest, and back (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic plaques n1=Xeroderma | n2=en:hyperkeratotic plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic plaques (face, elbow, knees) n1=Xeroderma | n2=en:hyperkeratotic plaques (face, elbow, knees) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic plaques on anterior knee area (in some patients) n1=Xeroderma | n2=en:hyperkeratotic plaques on anterior knee area (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic plaques on anterolateral ankle area (in some patients) n1=Xeroderma | n2=en:hyperkeratotic plaques on anterolateral ankle area (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic plaques on trunk and limbs n1=Xeroderma | n2=en:hyperkeratotic plaques on trunk and limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperkeratotic yellowish papules and plaques arranged linearly on palms and fingers n1=Xeroderma | n2=en:hyperkeratotic yellowish papules and plaques arranged linearly on palms and fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperlinearity of palms (in some patients) n1=Xeroderma | n2=en:hyperlinearity of palms (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypermelanotic macule n1=Xeroderma | n2=en:hypermelanotic macule | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmentation (in patients with kit mutations) n1=Xeroderma | n2=en:hyperpigmentation (in patients with kit mutations) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmentation (knuckles, elbows, axillae, areolae, pubic area) n1=Xeroderma | n2=en:hyperpigmentation (knuckles, elbows, axillae, areolae, pubic area) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmentation associated with increased adrenocorticotropic hormone (acth) n1=Xeroderma | n2=en:hyperpigmentation associated with increased adrenocorticotropic hormone (acth) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmentation in a reticular pattern primarily on flexural skin n1=Xeroderma | n2=en:hyperpigmentation in a reticular pattern primarily on flexural skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmentation in flexure areas n1=Xeroderma | n2=en:hyperpigmentation in flexure areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmentation in sun-exposed areas n1=Xeroderma | n2=en:hyperpigmentation in sun-exposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented 2 to 5-mm macules mainly on the extremities n1=Xeroderma | n2=en:hyperpigmented 2 to 5-mm macules mainly on the extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented erythematous lesions n1=Xeroderma | n2=en:hyperpigmented erythematous lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented lesions, 0.2-0.5 cm n1=Xeroderma | n2=en:hyperpigmented lesions, 0.2-0.5 cm | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented macules of variable size and shape located in a symmetrical pattern primarily on face, neck, trunk, and dorsa of hands and feet n1=Xeroderma | n2=en:hyperpigmented macules of variable size and shape located in a symmetrical pattern primarily on face, neck, trunk, and dorsa of hands and feet | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented nevi n1=Xeroderma | n2=en:hyperpigmented nevi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented nevi and streak n1=Xeroderma | n2=en:hyperpigmented nevi and streak | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented patches (in some patients) n1=Xeroderma | n2=en:hyperpigmented patches (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented rim with long fine hairs encircling the lesions (in some patients) n1=Xeroderma | n2=en:hyperpigmented rim with long fine hairs encircling the lesions (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented skin lesions (in some patients) n1=Xeroderma | n2=en:hyperpigmented skin lesions (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented skin patches (face, neck, trunk, limbs, lip, oral mucosa, palms, and soles) n1=Xeroderma | n2=en:hyperpigmented skin patches (face, neck, trunk, limbs, lip, oral mucosa, palms, and soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips n1=Xeroderma | n2=en:hyperpigmented spots on hands (especially palms), arms, feet (especially plantar areas), legs, and lips | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented streaks n1=Xeroderma | n2=en:hyperpigmented streaks | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented streaks following lines of blaschko n1=Xeroderma | n2=en:hyperpigmented streaks following lines of blaschko | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented whorls n1=Xeroderma | n2=en:hyperpigmented whorls | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented/hypopigmented macules (dorsum hands and feet, face) n1=Xeroderma | n2=en:hyperpigmented/hypopigmented macules (dorsum hands and feet, face) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hyperpigmented/hypopigmented macules (trunk, extremities, occasionally face) n1=Xeroderma | n2=en:hyperpigmented/hypopigmented macules (trunk, extremities, occasionally face) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypertrichosis n1=Xeroderma | n2=en:hypertrichosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypertrichosis (scalp, arms, legs, back) n1=Xeroderma | n2=en:hypertrichosis (scalp, arms, legs, back) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypertrophic disorder of skin, unspecified n1=Xeroderma | n2=en:hypertrophic disorder of skin, unspecified | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypertrophic scar n1=Xeroderma | n2=en:hypertrophic scar | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypertrophic scarring (rare) n1=Xeroderma | n2=en:hypertrophic scarring (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypertrophy of skin of soles n1=Xeroderma | n2=en:hypertrophy of skin of soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis n1=Xeroderma | n2=en:hypohidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis (in most patients) n1=Xeroderma | n2=en:hypohidrosis (in most patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis (in patients with hsan2d) n1=Xeroderma | n2=en:hypohidrosis (in patients with hsan2d) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis (in some patients) n1=Xeroderma | n2=en:hypohidrosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis and/or heat intolerance n1=Xeroderma | n2=en:hypohidrosis and/or heat intolerance | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis may be present n1=Xeroderma | n2=en:hypohidrosis may be present | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis or anhidrosis (in some patients) n1=Xeroderma | n2=en:hypohidrosis or anhidrosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis, localized, often on face n1=Xeroderma | n2=en:hypohidrosis, localized, often on face | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypohidrosis/hyperhidrosis n1=Xeroderma | n2=en:hypohidrosis/hyperhidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmentation (seen only in deletion cases) n1=Xeroderma | n2=en:hypopigmentation (seen only in deletion cases) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmentation in a reticular pattern primarily on flexural skin n1=Xeroderma | n2=en:hypopigmentation in a reticular pattern primarily on flexural skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmentation spots n1=Xeroderma | n2=en:hypopigmentation spots | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented macules n1=Xeroderma | n2=en:hypopigmented macules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented macules on neck, chest, and back (in some patients) n1=Xeroderma | n2=en:hypopigmented macules on neck, chest, and back (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented macules, primarily on extremities n1=Xeroderma | n2=en:hypopigmented macules, primarily on extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented patches (in some patients) n1=Xeroderma | n2=en:hypopigmented patches (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented skin lesions n1=Xeroderma | n2=en:hypopigmented skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented skin patch n1=Xeroderma | n2=en:hypopigmented skin patch | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented skin patches on arms (vitiligo) n1=Xeroderma | n2=en:hypopigmented skin patches on arms (vitiligo) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented spots (less common) n1=Xeroderma | n2=en:hypopigmented spots (less common) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypopigmented streaks n1=Xeroderma | n2=en:hypopigmented streaks | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypoplastic dermal ridges n1=Xeroderma | n2=en:hypoplastic dermal ridges | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypoplastic fingertip epidermal ridges n1=Xeroderma | n2=en:hypoplastic fingertip epidermal ridges | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypoplastic flexion creases n1=Xeroderma | n2=en:hypoplastic flexion creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypoplastic flexion creases dorsum of hand n1=Xeroderma | n2=en:hypoplastic flexion creases dorsum of hand | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypoplastic pilosebaceous units n1=Xeroderma | n2=en:hypoplastic pilosebaceous units | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypoplastic sweat glands n1=Xeroderma | n2=en:hypoplastic sweat glands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:hypoplastic-absent sebaceous glands n1=Xeroderma | n2=en:hypoplastic-absent sebaceous glands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosiform areas of skin (rare) n1=Xeroderma | n2=en:ichthyosiform areas of skin (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosiform erythroderma, congenital n1=Xeroderma | n2=en:ichthyosiform erythroderma, congenital | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis n1=Xeroderma | n2=en:ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis (1 family) n1=Xeroderma | n2=en:ichthyosis (1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis (in contiguous gene syndrome patients) n1=Xeroderma | n2=en:ichthyosis (in contiguous gene syndrome patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis (in some patients) n1=Xeroderma | n2=en:ichthyosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis (rare) n1=Xeroderma | n2=en:ichthyosis (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis aggravated n1=Xeroderma | n2=en:ichthyosis aggravated | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis hystrix n1=Xeroderma | n2=en:ichthyosis hystrix | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis of scalp and flexural areas n1=Xeroderma | n2=en:ichthyosis of scalp and flexural areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis vulgaris n1=Xeroderma | n2=en:ichthyosis vulgaris | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis, diffuse lamellar n1=Xeroderma | n2=en:ichthyosis, diffuse lamellar | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis, generalized, including flexures n1=Xeroderma | n2=en:ichthyosis, generalized, including flexures | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis, generalized, with involvement of flexural folds n1=Xeroderma | n2=en:ichthyosis, generalized, with involvement of flexural folds | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis n1=Xeroderma | n2=en:ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:impaired healing n1=Xeroderma | n2=en:impaired healing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:impaired self-care n1=Xeroderma | n2=en:impaired self-care | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:impaired would healing n1=Xeroderma | n2=en:impaired would healing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:impetigo n1=Xeroderma | n2=en:impetigo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:impetigo-like eruptions n1=Xeroderma | n2=en:impetigo-like eruptions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:increased chloride levels in sweat n1=Xeroderma | n2=en:increased chloride levels in sweat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:increased energy n1=Xeroderma | n2=en:increased energy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:increased mast cells n1=Xeroderma | n2=en:increased mast cells | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:increased number of skin folds (neck, abdomen, axillae) n1=Xeroderma | n2=en:increased number of skin folds (neck, abdomen, axillae) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:increased pigmented nevi n1=Xeroderma | n2=en:increased pigmented nevi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:induration n1=Xeroderma | n2=en:induration | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:infantile hemangioma n1=Xeroderma | n2=en:infantile hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:infected finger/toe/paronychia n1=Xeroderma | n2=en:infected finger/toe/paronychia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:infected fistula n1=Xeroderma | n2=en:infected fistula | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:inflammatory fistula n1=Xeroderma | n2=en:inflammatory fistula | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:influenza-like illness n1=Xeroderma | n2=en:influenza-like illness | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:infra-orbital crease n1=Xeroderma | n2=en:infra-orbital crease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:infraorbital fold (dennie-morgan lines) n1=Xeroderma | n2=en:infraorbital fold (dennie-morgan lines) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:infusion-related reaction n1=Xeroderma | n2=en:infusion-related reaction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ingrown toenail/other disease of nail n1=Xeroderma | n2=en:ingrown toenail/other disease of nail | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:inguinal freckling n1=Xeroderma | n2=en:inguinal freckling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:inguinal pterygium, bilateral (in some patients) n1=Xeroderma | n2=en:inguinal pterygium, bilateral (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:injection related reaction n1=Xeroderma | n2=en:injection related reaction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:inner zone of enucleated 'shadow' cells n1=Xeroderma | n2=en:inner zone of enucleated 'shadow' cells | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:insect bites n1=Xeroderma | n2=en:insect bites | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:intercrural pterygium n1=Xeroderma | n2=en:intercrural pterygium | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:intermittent generalized erythematous papular rash n1=Xeroderma | n2=en:intermittent generalized erythematous papular rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:intolerant of heat n1=Xeroderma | n2=en:intolerant of heat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:intracytoplasmic vacuoles in basal keratinocytes (with negative oil red o-staining) n1=Xeroderma | n2=en:intracytoplasmic vacuoles in basal keratinocytes (with negative oil red o-staining) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:irregular hyperpigmentation n1=Xeroderma | n2=en:irregular hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:irritability post vac n1=Xeroderma | n2=en:irritability post vac | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:irritation n1=Xeroderma | n2=en:irritation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:islands of uninvolved skin n1=Xeroderma | n2=en:islands of uninvolved skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:itching ( in some patients) n1=Xeroderma | n2=en:itching ( in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice n1=Xeroderma | n2=en:jaundice | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice (1 patient) n1=Xeroderma | n2=en:jaundice (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice (harderoporphyria) n1=Xeroderma | n2=en:jaundice (harderoporphyria) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice (in some patients) n1=Xeroderma | n2=en:jaundice (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice (in some patients), resolved postpartum n1=Xeroderma | n2=en:jaundice (in some patients), resolved postpartum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice (in some) n1=Xeroderma | n2=en:jaundice (in some) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice (less common) n1=Xeroderma | n2=en:jaundice (less common) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice (sometimes onset in the neonatal period) n1=Xeroderma | n2=en:jaundice (sometimes onset in the neonatal period) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice due to hemolytic anemia n1=Xeroderma | n2=en:jaundice due to hemolytic anemia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice, episodic n1=Xeroderma | n2=en:jaundice, episodic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice, green n1=Xeroderma | n2=en:jaundice, green | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice, intermittent (in some patients) n1=Xeroderma | n2=en:jaundice, intermittent (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:jaundice, neonatal (in some patients) n1=Xeroderma | n2=en:jaundice, neonatal (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:junctional epidermolysis bullosa n1=Xeroderma | n2=en:junctional epidermolysis bullosa | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:juvenile colloid milium n1=Xeroderma | n2=en:juvenile colloid milium | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keloid n1=Xeroderma | n2=en:keloid | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keloid formation n1=Xeroderma | n2=en:keloid formation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keloid formation in surgical scars n1=Xeroderma | n2=en:keloid formation in surgical scars | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratinized, purple, nodular skin lesions (in 2 of 4 patients) n1=Xeroderma | n2=en:keratinized, purple, nodular skin lesions (in 2 of 4 patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratinocyte n1=Xeroderma | n2=en:keratinocyte | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratitis-ichthyosis-deafness syndrome n1=Xeroderma | n2=en:keratitis-ichthyosis-deafness syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratoacanthoma n1=Xeroderma | n2=en:keratoacanthoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratoatrophoderma n1=Xeroderma | n2=en:keratoatrophoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratoderma (palms and soles) n1=Xeroderma | n2=en:keratoderma (palms and soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratoderma of soles at pressure points n1=Xeroderma | n2=en:keratoderma of soles at pressure points | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratoderma, mutilating, of palms and soles n1=Xeroderma | n2=en:keratoderma, mutilating, of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratoderma, striated, on palms n1=Xeroderma | n2=en:keratoderma, striated, on palms | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratosis n1=Xeroderma | n2=en:keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratosis palmaris n1=Xeroderma | n2=en:keratosis palmaris | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratosis pilaris n1=Xeroderma | n2=en:keratosis pilaris | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratosis pilaris (in some patients) n1=Xeroderma | n2=en:keratosis pilaris (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratosis pilaris of arms and legs n1=Xeroderma | n2=en:keratosis pilaris of arms and legs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratosis plantaris n1=Xeroderma | n2=en:keratosis plantaris | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratotic plaque, periorificial n1=Xeroderma | n2=en:keratotic plaque, periorificial | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:keratotic plaques (palms) n1=Xeroderma | n2=en:keratotic plaques (palms) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:knee dimple n1=Xeroderma | n2=en:knee dimple | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:knuckle pads on dorsal finger and toe joints n1=Xeroderma | n2=en:knuckle pads on dorsal finger and toe joints | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:laceration/cut n1=Xeroderma | n2=en:laceration/cut | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lack of chilblain lesions n1=Xeroderma | n2=en:lack of chilblain lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lack of epidermal ridges on palms and soles n1=Xeroderma | n2=en:lack of epidermal ridges on palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lack of perspiration n1=Xeroderma | n2=en:lack of perspiration | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lack of scarring n1=Xeroderma | n2=en:lack of scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lamellar ichthyosis n1=Xeroderma | n2=en:lamellar ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:langerhans cell n1=Xeroderma | n2=en:langerhans cell | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:large adherent dark pigmented scales n1=Xeroderma | n2=en:large adherent dark pigmented scales | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:large brownish scales on lower extremities (in some patients) n1=Xeroderma | n2=en:large brownish scales on lower extremities (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:large cafe au lait spots with irregular margins n1=Xeroderma | n2=en:large cafe au lait spots with irregular margins | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:large dark plate-like scales n1=Xeroderma | n2=en:large dark plate-like scales | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:large diamond-shaped plaques n1=Xeroderma | n2=en:large diamond-shaped plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:large hard compact painful masses of keratin at sites of recurrent friction on palms and soles n1=Xeroderma | n2=en:large hard compact painful masses of keratin at sites of recurrent friction on palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:large nevus (greater than 10 cm) n1=Xeroderma | n2=en:large nevus (greater than 10 cm) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:larger and darker scales on neck, elbows, and knees (in some patients) n1=Xeroderma | n2=en:larger and darker scales on neck, elbows, and knees (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:larger brownish scaling on neck, buttocks, and legs n1=Xeroderma | n2=en:larger brownish scaling on neck, buttocks, and legs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:leiomyomas are sensitive to light touch n1=Xeroderma | n2=en:leiomyomas are sensitive to light touch | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lentigenes n1=Xeroderma | n2=en:lentigenes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lentigines may be absent n1=Xeroderma | n2=en:lentigines may be absent | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lentigines may be congenital or develop in first months to years of life n1=Xeroderma | n2=en:lentigines may be congenital or develop in first months to years of life | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lentiginosis, generalized (in some patients) n1=Xeroderma | n2=en:lentiginosis, generalized (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions appear on the trunk and limbs but the face, palms, soles, and mucosa are spared n1=Xeroderma | n2=en:lesions appear on the trunk and limbs but the face, palms, soles, and mucosa are spared | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions are often brownish colored n1=Xeroderma | n2=en:lesions are often brownish colored | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions become purpuric n1=Xeroderma | n2=en:lesions become purpuric | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions become soft and paler with age n1=Xeroderma | n2=en:lesions become soft and paler with age | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions follow the lines of blaschko n1=Xeroderma | n2=en:lesions follow the lines of blaschko | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions occur mainly on extremities, scalp, neck, and trunk n1=Xeroderma | n2=en:lesions occur mainly on extremities, scalp, neck, and trunk | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions occur on the trunk, back, arms, legs, abdomen, buttocks n1=Xeroderma | n2=en:lesions occur on the trunk, back, arms, legs, abdomen, buttocks | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions often follow blaschko lines n1=Xeroderma | n2=en:lesions often follow blaschko lines | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lesions predominantly on face and limbs n1=Xeroderma | n2=en:lesions predominantly on face and limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:leukoplakia n1=Xeroderma | n2=en:leukoplakia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:leukoplakia (in some patients) n1=Xeroderma | n2=en:leukoplakia (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:leukoplakia (seen in recessive form) n1=Xeroderma | n2=en:leukoplakia (seen in recessive form) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lichenification n1=Xeroderma | n2=en:lichenification | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lichenification of palms n1=Xeroderma | n2=en:lichenification of palms | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lichenified lesions n1=Xeroderma | n2=en:lichenified lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lichenified skin n1=Xeroderma | n2=en:lichenified skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lichenoid plaques n1=Xeroderma | n2=en:lichenoid plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:light complexion n1=Xeroderma | n2=en:light complexion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:light skin pigmentation compared to unaffected sibs n1=Xeroderma | n2=en:light skin pigmentation compared to unaffected sibs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:light-sensitive dermatitis n1=Xeroderma | n2=en:light-sensitive dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lighter skin color n1=Xeroderma | n2=en:lighter skin color | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:limited dermatologic function n1=Xeroderma | n2=en:limited dermatologic function | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:linear arrays of macular hyperkeratoses in flexural areas n1=Xeroderma | n2=en:linear arrays of macular hyperkeratoses in flexural areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:linear epidermal nevus (in some patients) n1=Xeroderma | n2=en:linear epidermal nevus (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:linear hyperpigmentation n1=Xeroderma | n2=en:linear hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:linear nevus sebaceous, often in midfacial area n1=Xeroderma | n2=en:linear nevus sebaceous, often in midfacial area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:linear or reticular hyperpigmentation n1=Xeroderma | n2=en:linear or reticular hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:linear plaque-like scales (1 family) n1=Xeroderma | n2=en:linear plaque-like scales (1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:linear porokeratosis (1 patient) n1=Xeroderma | n2=en:linear porokeratosis (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lipofibroma n1=Xeroderma | n2=en:lipofibroma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lipohypoplasia n1=Xeroderma | n2=en:lipohypoplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lipoma n1=Xeroderma | n2=en:lipoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lipoma of skin and subcutaneous tissue of scalp n1=Xeroderma | n2=en:lipoma of skin and subcutaneous tissue of scalp | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:livedo n1=Xeroderma | n2=en:livedo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:livedo racemosa (usually on trunk and/or lower extremities) n1=Xeroderma | n2=en:livedo racemosa (usually on trunk and/or lower extremities) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:livedo reticularis n1=Xeroderma | n2=en:livedo reticularis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:livedo reticularis (1 patient) n1=Xeroderma | n2=en:livedo reticularis (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:local reaction n1=Xeroderma | n2=en:local reaction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:local swelling n1=Xeroderma | n2=en:local swelling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:local swelling/papules/lump/mass n1=Xeroderma | n2=en:local swelling/papules/lump/mass | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:localised rash n1=Xeroderma | n2=en:localised rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:localized cellulitis n1=Xeroderma | n2=en:localized cellulitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:localized cutaneous deposits of superficial fat n1=Xeroderma | n2=en:localized cutaneous deposits of superficial fat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:localized cutaneous necrobiosis lipoidica n1=Xeroderma | n2=en:localized cutaneous necrobiosis lipoidica | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:localized symmetric fixed, yellow- or red-brown hyperkeratotic plaques (extensor surface of extremities, buttocks, and lateral trunk) n1=Xeroderma | n2=en:localized symmetric fixed, yellow- or red-brown hyperkeratotic plaques (extensor surface of extremities, buttocks, and lateral trunk) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:longitudinal hyperkeratotic lesions along flexor surface of each finger, extending to palm n1=Xeroderma | n2=en:longitudinal hyperkeratotic lesions along flexor surface of each finger, extending to palm | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:loose redundant skin (especially of dorsum of hands and feet and anterior abdominal wall) n1=Xeroderma | n2=en:loose redundant skin (especially of dorsum of hands and feet and anterior abdominal wall) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:loose skin at birth n1=Xeroderma | n2=en:loose skin at birth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:loose volor skin of hands n1=Xeroderma | n2=en:loose volor skin of hands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:loose, elastic skin n1=Xeroderma | n2=en:loose, elastic skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:loose, redundant skin on fingers n1=Xeroderma | n2=en:loose, redundant skin on fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:loss of subcutaneous fat n1=Xeroderma | n2=en:loss of subcutaneous fat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lower limb lymphedema (variable onset, age four to teens) n1=Xeroderma | n2=en:lower limb lymphedema (variable onset, age four to teens) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lymphangioma n1=Xeroderma | n2=en:lymphangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lymphatic vessels present at the periphery of lesion n1=Xeroderma | n2=en:lymphatic vessels present at the periphery of lesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:lymphedema n1=Xeroderma | n2=en:lymphedema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:maceration of palms and soles n1=Xeroderma | n2=en:maceration of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:macrosomia n1=Xeroderma | n2=en:macrosomia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:macular hemangioma n1=Xeroderma | n2=en:macular hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:macular hypopigmented whorls, streaks, and patches n1=Xeroderma | n2=en:macular hypopigmented whorls, streaks, and patches | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:maculopapular eruption, diffuse n1=Xeroderma | n2=en:maculopapular eruption, diffuse | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:maculopapular rash, episodic n1=Xeroderma | n2=en:maculopapular rash, episodic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:malar flush n1=Xeroderma | n2=en:malar flush | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:malar rash n1=Xeroderma | n2=en:malar rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:malignant skin neoplasm n1=Xeroderma | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:marbled skin due to telangiectasia n1=Xeroderma | n2=en:marbled skin due to telangiectasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:marked bruisability n1=Xeroderma | n2=en:marked bruisability | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:marked skin pallor n1=Xeroderma | n2=en:marked skin pallor | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mast cell degranulation n1=Xeroderma | n2=en:mast cell degranulation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mature adipocytes n1=Xeroderma | n2=en:mature adipocytes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mechanically fragile skin n1=Xeroderma | n2=en:mechanically fragile skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:melanocytic nevus n1=Xeroderma | n2=en:melanocytic nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:melanocytic skin tumors/papules, skin-colored to reddish-brown, dome-shaped or pedunculated, well circumscribed with an average size of 5 mm (in 2 families) n1=Xeroderma | n2=en:melanocytic skin tumors/papules, skin-colored to reddish-brown, dome-shaped or pedunculated, well circumscribed with an average size of 5 mm (in 2 families) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:meteoropathy n1=Xeroderma | n2=en:meteoropathy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:microlithiasis n1=Xeroderma | n2=en:microlithiasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:midface capillary hemangioma n1=Xeroderma | n2=en:midface capillary hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:midfrontal capillary hemangioma n1=Xeroderma | n2=en:midfrontal capillary hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:midline facial capillary hemangioma n1=Xeroderma | n2=en:midline facial capillary hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:migratory ichthyosiform dermatosis n1=Xeroderma | n2=en:migratory ichthyosiform dermatosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:migratory plaques of thickened, sharply demarcated erythema and hyperkeratosis n1=Xeroderma | n2=en:migratory plaques of thickened, sharply demarcated erythema and hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:migratory rashes, painful n1=Xeroderma | n2=en:migratory rashes, painful | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild atrophic scarring n1=Xeroderma | n2=en:mild atrophic scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild cutaneous changes n1=Xeroderma | n2=en:mild cutaneous changes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild diffuse ichthyosis n1=Xeroderma | n2=en:mild diffuse ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild eczema n1=Xeroderma | n2=en:mild eczema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild hyperkeratosis n1=Xeroderma | n2=en:mild hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild hyperkeratosis of palms n1=Xeroderma | n2=en:mild hyperkeratosis of palms | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild hypopigmentation (in light-skinned individuals) n1=Xeroderma | n2=en:mild hypopigmentation (in light-skinned individuals) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild lamellar ichthyosis n1=Xeroderma | n2=en:mild lamellar ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild localized pigmentation abnormalities n1=Xeroderma | n2=en:mild localized pigmentation abnormalities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild scarring n1=Xeroderma | n2=en:mild scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild skin hyperextensibility n1=Xeroderma | n2=en:mild skin hyperextensibility | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild tissue fragility n1=Xeroderma | n2=en:mild tissue fragility | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild-moderate bruisability n1=Xeroderma | n2=en:mild-moderate bruisability | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild-to-severe pterygia n1=Xeroderma | n2=en:mild-to-severe pterygia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mild/severe skin hypopigmentation n1=Xeroderma | n2=en:mild/severe skin hypopigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mildly extensible skin n1=Xeroderma | n2=en:mildly extensible skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:milia (less common) n1=Xeroderma | n2=en:milia (less common) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:milia (rare) n1=Xeroderma | n2=en:milia (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:milia of upper face and ears (infancy) n1=Xeroderma | n2=en:milia of upper face and ears (infancy) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:milium cyst n1=Xeroderma | n2=en:milium cyst | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:milky white skin n1=Xeroderma | n2=en:milky white skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:minimal or absent scarring n1=Xeroderma | n2=en:minimal or absent scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:moderate erythroderma n1=Xeroderma | n2=en:moderate erythroderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:moderate scarring n1=Xeroderma | n2=en:moderate scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:moderate to severe acne n1=Xeroderma | n2=en:moderate to severe acne | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:molluscoid pseudotumors n1=Xeroderma | n2=en:molluscoid pseudotumors | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:molluscum contagiosum n1=Xeroderma | n2=en:molluscum contagiosum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:moniliasis/candida (excluding x72 y75) n1=Xeroderma | n2=en:moniliasis/candida (excluding x72 y75) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:morbilliform eruption n1=Xeroderma | n2=en:morbilliform eruption | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:most evident on lower legs n1=Xeroderma | n2=en:most evident on lower legs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mottled pigmentation n1=Xeroderma | n2=en:mottled pigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mottled pigmentation of photoexposed areas n1=Xeroderma | n2=en:mottled pigmentation of photoexposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mottled pigmentation of the trunk and proximal extremities n1=Xeroderma | n2=en:mottled pigmentation of the trunk and proximal extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mucocutaneous candidiasis n1=Xeroderma | n2=en:mucocutaneous candidiasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mucosal lesions n1=Xeroderma | n2=en:mucosal lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mucosal lesions affecting all regions (i.e., oral, nasal, vaginal, anal, bladder, conjunctival regions) n1=Xeroderma | n2=en:mucosal lesions affecting all regions (i.e., oral, nasal, vaginal, anal, bladder, conjunctival regions) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mulitple papules (1-2 mm skin colored and hyperpigmented) n1=Xeroderma | n2=en:mulitple papules (1-2 mm skin colored and hyperpigmented) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multi-organ disorder n1=Xeroderma | n2=en:multi-organ disorder | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multimorbidities n1=Xeroderma | n2=en:multimorbidities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple asymptomatic papules with atrophic white scar-like centers surrounded by telangiectatic borders n1=Xeroderma | n2=en:multiple asymptomatic papules with atrophic white scar-like centers surrounded by telangiectatic borders | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple facial papules n1=Xeroderma | n2=en:multiple facial papules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple gingival papules n1=Xeroderma | n2=en:multiple gingival papules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple lentigines n1=Xeroderma | n2=en:multiple lentigines | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple nevi n1=Xeroderma | n2=en:multiple nevi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple nevi (face and torso) n1=Xeroderma | n2=en:multiple nevi (face and torso) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple nevi (up to hundreds) n1=Xeroderma | n2=en:multiple nevi (up to hundreds) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple organ failure n1=Xeroderma | n2=en:multiple organ failure | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple palmar creases n1=Xeroderma | n2=en:multiple palmar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple papules (milium-like, comedo-like) n1=Xeroderma | n2=en:multiple papules (milium-like, comedo-like) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple pigmented moles n1=Xeroderma | n2=en:multiple pigmented moles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple pterygia n1=Xeroderma | n2=en:multiple pterygia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple skin tags n1=Xeroderma | n2=en:multiple skin tags | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple small nevi (rare) n1=Xeroderma | n2=en:multiple small nevi (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple, asymptomatic dermal cysts (trunk, proximal extremities, neck, axillae, inguinal region, scalp) n1=Xeroderma | n2=en:multiple, asymptomatic dermal cysts (trunk, proximal extremities, neck, axillae, inguinal region, scalp) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple, flat, skin-colored warty papules (2-4mm in diameter on dorsum hands, feet, knees, and elbows) n1=Xeroderma | n2=en:multiple, flat, skin-colored warty papules (2-4mm in diameter on dorsum hands, feet, knees, and elbows) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple, red-blue, soft, compressible vascular papules or macules (especially on trunk or upper arms) n1=Xeroderma | n2=en:multiple, red-blue, soft, compressible vascular papules or macules (especially on trunk or upper arms) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:multiple, small punctate keratoses (palms and soles) n1=Xeroderma | n2=en:multiple, small punctate keratoses (palms and soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:mutilating skin deformity n1=Xeroderma | n2=en:mutilating skin deformity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:myxedema (untreated hypothyroidism) n1=Xeroderma | n2=en:myxedema (untreated hypothyroidism) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neck skin n1=Xeroderma | n2=en:neck skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:necrosis leading to amputation (in some patients) n1=Xeroderma | n2=en:necrosis leading to amputation (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:necrotic skin ulcers (in 1 patient) n1=Xeroderma | n2=en:necrotic skin ulcers (in 1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neonatal acral blistering n1=Xeroderma | n2=en:neonatal acral blistering | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neonatal blisters and erosions n1=Xeroderma | n2=en:neonatal blisters and erosions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neonatal collodion skin n1=Xeroderma | n2=en:neonatal collodion skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neonatal cyanosis n1=Xeroderma | n2=en:neonatal cyanosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neonatal jaundice n1=Xeroderma | n2=en:neonatal jaundice | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neonatal multi-organ failure n1=Xeroderma | n2=en:neonatal multi-organ failure | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neonatal purpura fulminans n1=Xeroderma | n2=en:neonatal purpura fulminans | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:netherton syndrome n1=Xeroderma | n2=en:netherton syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neurofibroma n1=Xeroderma | n2=en:neurofibroma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neurofibromas may or may not be present n1=Xeroderma | n2=en:neurofibromas may or may not be present | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neurofibromas, cutaneous (86%) n1=Xeroderma | n2=en:neurofibromas, cutaneous (86%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:neurofibromas, subcutaneous (76%) n1=Xeroderma | n2=en:neurofibromas, subcutaneous (76%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nevi flammei (philtrum, nape of neck, forehead) n1=Xeroderma | n2=en:nevi flammei (philtrum, nape of neck, forehead) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nevus araneus n1=Xeroderma | n2=en:nevus araneus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nevus flammeus (eyelids and nape of neck) n1=Xeroderma | n2=en:nevus flammeus (eyelids and nape of neck) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nevus flammeus of the forehead n1=Xeroderma | n2=en:nevus flammeus of the forehead | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nevus flammus n1=Xeroderma | n2=en:nevus flammus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nevus/mole n1=Xeroderma | n2=en:nevus/mole | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:night sweats n1=Xeroderma | n2=en:night sweats | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nipple dermatitis n1=Xeroderma | n2=en:nipple dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no ability to tan n1=Xeroderma | n2=en:no ability to tan | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no abnormal skin pigmentation n1=Xeroderma | n2=en:no abnormal skin pigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no abnormalities of sweating n1=Xeroderma | n2=en:no abnormalities of sweating | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no cutaneous photosensitivity n1=Xeroderma | n2=en:no cutaneous photosensitivity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no easy bruisability n1=Xeroderma | n2=en:no easy bruisability | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no eczema n1=Xeroderma | n2=en:no eczema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no erythema n1=Xeroderma | n2=en:no erythema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no hemorrhage n1=Xeroderma | n2=en:no hemorrhage | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no hyperhidrosis n1=Xeroderma | n2=en:no hyperhidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no ichthyosis n1=Xeroderma | n2=en:no ichthyosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no increased bruisability n1=Xeroderma | n2=en:no increased bruisability | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no inflammatory or bullous skin lesions n1=Xeroderma | n2=en:no inflammatory or bullous skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no mucosal vesicles n1=Xeroderma | n2=en:no mucosal vesicles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no palmoplantar hyperkeratosis n1=Xeroderma | n2=en:no palmoplantar hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no palmoplantar keratosis n1=Xeroderma | n2=en:no palmoplantar keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no pruritis n1=Xeroderma | n2=en:no pruritis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no scarring n1=Xeroderma | n2=en:no scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no skin hyperelasticity n1=Xeroderma | n2=en:no skin hyperelasticity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no systemic vascular lesions n1=Xeroderma | n2=en:no systemic vascular lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no tanning n1=Xeroderma | n2=en:no tanning | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:no uv-induced skin tumors n1=Xeroderma | n2=en:no uv-induced skin tumors | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nodular lesion n1=Xeroderma | n2=en:nodular lesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nodular skin lesions n1=Xeroderma | n2=en:nodular skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nodule n1=Xeroderma | n2=en:nodule | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nodule show lipid-laden macrophages n1=Xeroderma | n2=en:nodule show lipid-laden macrophages | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:non pruritic n1=Xeroderma | n2=en:non pruritic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:non-glabrous skin n1=Xeroderma | n2=en:non-glabrous skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:non-purpuric punctate and linear erythematous rash n1=Xeroderma | n2=en:non-purpuric punctate and linear erythematous rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:non-scarring skin blistering (hands, feet, elbow, knee - onset in adolescence) n1=Xeroderma | n2=en:non-scarring skin blistering (hands, feet, elbow, knee - onset in adolescence) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nonmelanoma skin cancer (in some patients) n1=Xeroderma | n2=en:nonmelanoma skin cancer (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:nonscarring blisters (hand, feet, forearms) n1=Xeroderma | n2=en:nonscarring blisters (hand, feet, forearms) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal numbers of sweat glands n1=Xeroderma | n2=en:normal numbers of sweat glands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal scarring n1=Xeroderma | n2=en:normal scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal skin n1=Xeroderma | n2=en:normal skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal skin (no palmoplantar keratoderma) n1=Xeroderma | n2=en:normal skin (no palmoplantar keratoderma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal sweat electrolytes n1=Xeroderma | n2=en:normal sweat electrolytes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal sweat glands n1=Xeroderma | n2=en:normal sweat glands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal sweating n1=Xeroderma | n2=en:normal sweating | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:normal sweating capacity n1=Xeroderma | n2=en:normal sweating capacity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:numbness, pain, and tingling of the fingers in response to cold n1=Xeroderma | n2=en:numbness, pain, and tingling of the fingers in response to cold | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:numerous 'confetti-like' scattered patches of normal skin n1=Xeroderma | n2=en:numerous 'confetti-like' scattered patches of normal skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:numerous congenital melanocytic nevi n1=Xeroderma | n2=en:numerous congenital melanocytic nevi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:numerous nevi n1=Xeroderma | n2=en:numerous nevi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:numerous pigmented freckles n1=Xeroderma | n2=en:numerous pigmented freckles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:obstruction n1=Xeroderma | n2=en:obstruction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:occasional cafe-au-lait spots n1=Xeroderma | n2=en:occasional cafe-au-lait spots | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:occasional neurofibromas n1=Xeroderma | n2=en:occasional neurofibromas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:occurs in linear distribution n1=Xeroderma | n2=en:occurs in linear distribution | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:odoriferous,, hypertrophic plaques n1=Xeroderma | n2=en:odoriferous,, hypertrophic plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:oily skin n1=Xeroderma | n2=en:oily skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:onset birth-newborn period n1=Xeroderma | n2=en:onset birth-newborn period | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:organ failure n1=Xeroderma | n2=en:organ failure | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:orthokeratosis n1=Xeroderma | n2=en:orthokeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:orthostatic acrocyanosis n1=Xeroderma | n2=en:orthostatic acrocyanosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other benign neoplasm of skin, unspecified n1=Xeroderma | n2=en:other benign neoplasm of skin, unspecified | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other changes in skin color n1=Xeroderma | n2=en:other changes in skin color | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other dermatologic congenital anomalies n1=Xeroderma | n2=en:other dermatologic congenital anomalies | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other disorders of the skin and subcutaneous tissue n1=Xeroderma | n2=en:other disorders of the skin and subcutaneous tissue | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other ill-defined conditions n1=Xeroderma | n2=en:other ill-defined conditions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other infectious skin disease n1=Xeroderma | n2=en:other infectious skin disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other injury to skin n1=Xeroderma | n2=en:other injury to skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other localized skin infection n1=Xeroderma | n2=en:other localized skin infection | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other specified dermatoses n1=Xeroderma | n2=en:other specified dermatoses | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other symptom/complaint skin n1=Xeroderma | n2=en:other symptom/complaint skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other symptoms involving skin and integumentary tissues n1=Xeroderma | n2=en:other symptoms involving skin and integumentary tissues | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:other/unspecified neoplasm skin n1=Xeroderma | n2=en:other/unspecified neoplasm skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:overlapping lesion of skin n1=Xeroderma | n2=en:overlapping lesion of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pachyderma n1=Xeroderma | n2=en:pachyderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pain/tenderness of skin n1=Xeroderma | n2=en:pain/tenderness of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:painful bluish-red papules or nodules (fingers, toes, nose, cheek, ears) n1=Xeroderma | n2=en:painful bluish-red papules or nodules (fingers, toes, nose, cheek, ears) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:painful, fleshy papules or nodules (hands, scalp, ears, perinasal area) n1=Xeroderma | n2=en:painful, fleshy papules or nodules (hands, scalp, ears, perinasal area) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pale-gray skin n1=Xeroderma | n2=en:pale-gray skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pale, sensitive skin n1=Xeroderma | n2=en:pale, sensitive skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pallor n1=Xeroderma | n2=en:pallor | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pallor (in some patients) n1=Xeroderma | n2=en:pallor (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pallor during episodes n1=Xeroderma | n2=en:pallor during episodes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pallor of skin n1=Xeroderma | n2=en:pallor of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar creases, fine to acrogeria-like n1=Xeroderma | n2=en:palmar creases, fine to acrogeria-like | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar erythema n1=Xeroderma | n2=en:palmar erythema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar hyperhidrosis n1=Xeroderma | n2=en:palmar hyperhidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar hyperlinearity n1=Xeroderma | n2=en:palmar hyperlinearity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar keratosis n1=Xeroderma | n2=en:palmar keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar nevi n1=Xeroderma | n2=en:palmar nevi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar pit n1=Xeroderma | n2=en:palmar pit | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar telangiectasias (described in 1 family) n1=Xeroderma | n2=en:palmar telangiectasias (described in 1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar wrinkling n1=Xeroderma | n2=en:palmar wrinkling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmar xanthomas n1=Xeroderma | n2=en:palmar xanthomas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar cutis gyrata n1=Xeroderma | n2=en:palmoplantar cutis gyrata | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar cutis laxa n1=Xeroderma | n2=en:palmoplantar cutis laxa | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar epidermolytic hyperkeratosis along blaschko lines (rare) n1=Xeroderma | n2=en:palmoplantar epidermolytic hyperkeratosis along blaschko lines (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar hyperhidrosis (in some patients) n1=Xeroderma | n2=en:palmoplantar hyperhidrosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar hyperkeratosis, mild (in some patients) n1=Xeroderma | n2=en:palmoplantar hyperkeratosis, mild (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar hyperkeratosis, severe n1=Xeroderma | n2=en:palmoplantar hyperkeratosis, severe | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar hyperlinearity n1=Xeroderma | n2=en:palmoplantar hyperlinearity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar hyperlinearity, marked n1=Xeroderma | n2=en:palmoplantar hyperlinearity, marked | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar keratoderma n1=Xeroderma | n2=en:palmoplantar keratoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar keratoderma (in some patients) n1=Xeroderma | n2=en:palmoplantar keratoderma (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar keratoderma, diffuse (in some patients) n1=Xeroderma | n2=en:palmoplantar keratoderma, diffuse (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar keratoderma, mild n1=Xeroderma | n2=en:palmoplantar keratoderma, mild | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar keratoderma, mild (in homozygous patients) n1=Xeroderma | n2=en:palmoplantar keratoderma, mild (in homozygous patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar keratoderma, patchy (>50%) n1=Xeroderma | n2=en:palmoplantar keratoderma, patchy (>50%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar keratosis with erythema and scale n1=Xeroderma | n2=en:palmoplantar keratosis with erythema and scale | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palmoplantar pits n1=Xeroderma | n2=en:palmoplantar pits | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:palms, soles, and oral mucosa are not involved n1=Xeroderma | n2=en:palms, soles, and oral mucosa are not involved | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:panniculitis n1=Xeroderma | n2=en:panniculitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papillomas (perioral, nasal, and anal regions) n1=Xeroderma | n2=en:papillomas (perioral, nasal, and anal regions) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papillomatosis n1=Xeroderma | n2=en:papillomatosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papillomatosis of affected area n1=Xeroderma | n2=en:papillomatosis of affected area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papillomatosis over affected area n1=Xeroderma | n2=en:papillomatosis over affected area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papillomatosis over edematous areas n1=Xeroderma | n2=en:papillomatosis over edematous areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papillomatosis, confluent centrally, erythematous turning brown later n1=Xeroderma | n2=en:papillomatosis, confluent centrally, erythematous turning brown later | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papillomatosis, reticular on the periphery, 1 to 2-mm growing to 4-5-mm and coalescing n1=Xeroderma | n2=en:papillomatosis, reticular on the periphery, 1 to 2-mm growing to 4-5-mm and coalescing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papular keratoderma, mild n1=Xeroderma | n2=en:papular keratoderma, mild | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papular lesion n1=Xeroderma | n2=en:papular lesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papules enlarge centrifugally to form central atrophic area with an irregular keratotic ridge n1=Xeroderma | n2=en:papules enlarge centrifugally to form central atrophic area with an irregular keratotic ridge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papules enlarge centrifugally to form central atrophic area with an irregular peripheral keratotic ridge n1=Xeroderma | n2=en:papules enlarge centrifugally to form central atrophic area with an irregular peripheral keratotic ridge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papules, firm, flat or dome-shaped, skin-colored some with a hair at or just outside the periphery and/or telangiectatic surface n1=Xeroderma | n2=en:papules, firm, flat or dome-shaped, skin-colored some with a hair at or just outside the periphery and/or telangiectatic surface | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papules, keratotic follicular n1=Xeroderma | n2=en:papules, keratotic follicular | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:papulosquamous erythematous plaques n1=Xeroderma | n2=en:papulosquamous erythematous plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:paradoxical sweating response (sweating induced by cold exposure, inability to sweat in hot weather) n1=Xeroderma | n2=en:paradoxical sweating response (sweating induced by cold exposure, inability to sweat in hot weather) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:parakeratosis n1=Xeroderma | n2=en:parakeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:partial anhidrosis n1=Xeroderma | n2=en:partial anhidrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:patchy vitiligo n1=Xeroderma | n2=en:patchy vitiligo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:patchy, reticular stains n1=Xeroderma | n2=en:patchy, reticular stains | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:peau d'orange n1=Xeroderma | n2=en:peau d'orange | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pebbly skin lesions on back, upper arms, and thigh n1=Xeroderma | n2=en:pebbly skin lesions on back, upper arms, and thigh | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pediculosis/other skin infestation n1=Xeroderma | n2=en:pediculosis/other skin infestation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pemphigus n1=Xeroderma | n2=en:pemphigus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:perforation n1=Xeroderma | n2=en:perforation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:performance status decreased n1=Xeroderma | n2=en:performance status decreased | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:perianal erythema n1=Xeroderma | n2=en:perianal erythema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:perianal skin tags n1=Xeroderma | n2=en:perianal skin tags | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:periarticular subcutaneous nodules n1=Xeroderma | n2=en:periarticular subcutaneous nodules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:perinasal or perioral nonhealing crusting of the skin n1=Xeroderma | n2=en:perinasal or perioral nonhealing crusting of the skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:perineal intertrigo n1=Xeroderma | n2=en:perineal intertrigo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:perioral erythema n1=Xeroderma | n2=en:perioral erythema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:periorbital hyperpigmentation n1=Xeroderma | n2=en:periorbital hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:periorbital wrinkles n1=Xeroderma | n2=en:periorbital wrinkles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:periorificial hyperkeratotic lesions n1=Xeroderma | n2=en:periorificial hyperkeratotic lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:peripheral swelling n1=Xeroderma | n2=en:peripheral swelling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:peristomal skin n1=Xeroderma | n2=en:peristomal skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:petechia n1=Xeroderma | n2=en:petechia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:petechiae (less common) n1=Xeroderma | n2=en:petechiae (less common) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:petechiae and purpura do not occur n1=Xeroderma | n2=en:petechiae and purpura do not occur | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:photosensitivity (harderoporphyria and hcp) n1=Xeroderma | n2=en:photosensitivity (harderoporphyria and hcp) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:photosensitivity bullous dermatitis (1 patient) n1=Xeroderma | n2=en:photosensitivity bullous dermatitis (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:piebaldism n1=Xeroderma | n2=en:piebaldism | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigment changes n1=Xeroderma | n2=en:pigment changes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigmentary abnormalities n1=Xeroderma | n2=en:pigmentary abnormalities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigmentary abnormalities (in some patients) n1=Xeroderma | n2=en:pigmentary abnormalities (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigmentary change in skin n1=Xeroderma | n2=en:pigmentary change in skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigmentary changes on the shins (1 patient) n1=Xeroderma | n2=en:pigmentary changes on the shins (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigmentation n1=Xeroderma | n2=en:pigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigmentation abnormalities (1 family) n1=Xeroderma | n2=en:pigmentation abnormalities (1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pigmented nevus n1=Xeroderma | n2=en:pigmented nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pilo-sebaceous apparatus n1=Xeroderma | n2=en:pilo-sebaceous apparatus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pilomatricoma n1=Xeroderma | n2=en:pilomatricoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pilonidal cyst n1=Xeroderma | n2=en:pilonidal cyst | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pilonidal cyst/fistula n1=Xeroderma | n2=en:pilonidal cyst/fistula | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pits of palms and soles n1=Xeroderma | n2=en:pits of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pitted, perioral acneiform scars n1=Xeroderma | n2=en:pitted, perioral acneiform scars | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pityriasis alba n1=Xeroderma | n2=en:pityriasis alba | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pityriasis rosea n1=Xeroderma | n2=en:pityriasis rosea | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:planar xanthomas (detroit type 107680.0011) n1=Xeroderma | n2=en:planar xanthomas (detroit type 107680.0011) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:planar xanthomas in homozygotes n1=Xeroderma | n2=en:planar xanthomas in homozygotes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plantar blistering n1=Xeroderma | n2=en:plantar blistering | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plantar hyperkeratosis n1=Xeroderma | n2=en:plantar hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plantar keratoderma (in some patients) n1=Xeroderma | n2=en:plantar keratoderma (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plantar pits n1=Xeroderma | n2=en:plantar pits | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plantar softness n1=Xeroderma | n2=en:plantar softness | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plaque-like facial hemangioma n1=Xeroderma | n2=en:plaque-like facial hemangioma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plaques, erythematous, covered with fine powdery scales n1=Xeroderma | n2=en:plaques, erythematous, covered with fine powdery scales | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plexiform neurofibroma n1=Xeroderma | n2=en:plexiform neurofibroma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:plexiform neurofibroma (76%) n1=Xeroderma | n2=en:plexiform neurofibroma (76%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pneumatosis n1=Xeroderma | n2=en:pneumatosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poikiloderma n1=Xeroderma | n2=en:poikiloderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poikiloderma (atrophic plaques with telangiectasia) n1=Xeroderma | n2=en:poikiloderma (atrophic plaques with telangiectasia) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poor healing with abnormal scarring (in some patients) n1=Xeroderma | n2=en:poor healing with abnormal scarring (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poor sweating in response to heat n1=Xeroderma | n2=en:poor sweating in response to heat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poor wound healing n1=Xeroderma | n2=en:poor wound healing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poorly defined palmar creases n1=Xeroderma | n2=en:poorly defined palmar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poorly developed palmar creases n1=Xeroderma | n2=en:poorly developed palmar creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:popliteal pterygium n1=Xeroderma | n2=en:popliteal pterygium | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:popliteal pterygium, bilateral n1=Xeroderma | n2=en:popliteal pterygium, bilateral | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:porokeratosis n1=Xeroderma | n2=en:porokeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:poroma n1=Xeroderma | n2=en:poroma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:port wine stain n1=Xeroderma | n2=en:port wine stain | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:positive skin test reaction to seminal fluid n1=Xeroderma | n2=en:positive skin test reaction to seminal fluid | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:post cardiac arrest syndrome n1=Xeroderma | n2=en:post cardiac arrest syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:postauricular crescent-shaped hypoplastic skin lesion n1=Xeroderma | n2=en:postauricular crescent-shaped hypoplastic skin lesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:posterior midline scalp defects n1=Xeroderma | n2=en:posterior midline scalp defects | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:postnatal-onset ichthyosiform erythroderma n1=Xeroderma | n2=en:postnatal-onset ichthyosiform erythroderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:postoperative hemorrhage n1=Xeroderma | n2=en:postoperative hemorrhage | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pre-existing condition n1=Xeroderma | n2=en:pre-existing condition | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pre-existing condition improved n1=Xeroderma | n2=en:pre-existing condition improved | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:premature aging (in some patients) n1=Xeroderma | n2=en:premature aging (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:premature aging syndrome n1=Xeroderma | n2=en:premature aging syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:premature aging, mild n1=Xeroderma | n2=en:premature aging, mild | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prepuce n1=Xeroderma | n2=en:prepuce | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pretibial dimples n1=Xeroderma | n2=en:pretibial dimples | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pretibial pigmented granulomatous plaques n1=Xeroderma | n2=en:pretibial pigmented granulomatous plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:primarily affects trunk n1=Xeroderma | n2=en:primarily affects trunk | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:profuse pigmented skin lesions n1=Xeroderma | n2=en:profuse pigmented skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:profuse sweating of the upper body induced by cold exposure n1=Xeroderma | n2=en:profuse sweating of the upper body induced by cold exposure | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:progeric skin changes n1=Xeroderma | n2=en:progeric skin changes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:progression of skin lesions - n1=Xeroderma | n2=en:progression of skin lesions - | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:progressive cutis verticis gyrata n1=Xeroderma | n2=en:progressive cutis verticis gyrata | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:progressive generalized skin erosions n1=Xeroderma | n2=en:progressive generalized skin erosions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:progressive reticulate hyperpigmentation (axillae, groin, perineal, perianal) n1=Xeroderma | n2=en:progressive reticulate hyperpigmentation (axillae, groin, perineal, perianal) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:progressive vitiligo n1=Xeroderma | n2=en:progressive vitiligo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prolapse n1=Xeroderma | n2=en:prolapse | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:proliferating cells show nuclear expression of lymphoid enhancer binding factor-1 (lef1, 153245) n1=Xeroderma | n2=en:proliferating cells show nuclear expression of lymphoid enhancer binding factor-1 (lef1, 153245) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:proliferation of spindle cells n1=Xeroderma | n2=en:proliferation of spindle cells | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prolonged capillary refill n1=Xeroderma | n2=en:prolonged capillary refill | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent fingertip pads n1=Xeroderma | n2=en:prominent fingertip pads | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent palmar flexion creases n1=Xeroderma | n2=en:prominent palmar flexion creases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent scalp veins n1=Xeroderma | n2=en:prominent scalp veins | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent superficial blood vessels n1=Xeroderma | n2=en:prominent superficial blood vessels | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent superficial blood vessels due to thin skin n1=Xeroderma | n2=en:prominent superficial blood vessels due to thin skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent superficial veins n1=Xeroderma | n2=en:prominent superficial veins | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent superficial venous pattern n1=Xeroderma | n2=en:prominent superficial venous pattern | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent vasculature (nose and forehead) n1=Xeroderma | n2=en:prominent vasculature (nose and forehead) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent veins n1=Xeroderma | n2=en:prominent veins | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent veins (especially over scalp and limbs) n1=Xeroderma | n2=en:prominent veins (especially over scalp and limbs) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent veins on scalp, trunk, and/or extremities n1=Xeroderma | n2=en:prominent veins on scalp, trunk, and/or extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent venous markings n1=Xeroderma | n2=en:prominent venous markings | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prominent venous pattern n1=Xeroderma | n2=en:prominent venous pattern | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:prurigo n1=Xeroderma | n2=en:prurigo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritic eczematous lesions n1=Xeroderma | n2=en:pruritic eczematous lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritic hyperkeratotic scars (in some patients) n1=Xeroderma | n2=en:pruritic hyperkeratotic scars (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritic ichthyosis (onset birth to first several months) n1=Xeroderma | n2=en:pruritic ichthyosis (onset birth to first several months) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritis, cold-induced n1=Xeroderma | n2=en:pruritis, cold-induced | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritis, intense n1=Xeroderma | n2=en:pruritis, intense | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus n1=Xeroderma | n2=en:pruritus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus (inflammatory type b) n1=Xeroderma | n2=en:pruritus (inflammatory type b) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus (major feature) n1=Xeroderma | n2=en:pruritus (major feature) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus during pregnancy, resolves postpartum n1=Xeroderma | n2=en:pruritus during pregnancy, resolves postpartum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus in affected areas n1=Xeroderma | n2=en:pruritus in affected areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus of scalp n1=Xeroderma | n2=en:pruritus of scalp | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus of skin lesions, severe n1=Xeroderma | n2=en:pruritus of skin lesions, severe | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus secondary to liver disease n1=Xeroderma | n2=en:pruritus secondary to liver disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pruritus, episodic n1=Xeroderma | n2=en:pruritus, episodic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pseudoainhum n1=Xeroderma | n2=en:pseudoainhum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pseudoainhum of fifth toes n1=Xeroderma | n2=en:pseudoainhum of fifth toes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pseudocyst n1=Xeroderma | n2=en:pseudocyst | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pseudoxanthomatous skin lesions (in some patients) n1=Xeroderma | n2=en:pseudoxanthomatous skin lesions (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:psoriasiform dermatitis (in some patients) n1=Xeroderma | n2=en:psoriasiform dermatitis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:psoriasiform lesions (rare) n1=Xeroderma | n2=en:psoriasiform lesions (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:psoriasiform plaques n1=Xeroderma | n2=en:psoriasiform plaques | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:psoriasiform skin lesions n1=Xeroderma | n2=en:psoriasiform skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:psoriasis n1=Xeroderma | n2=en:psoriasis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:psoriasis (in some patients) n1=Xeroderma | n2=en:psoriasis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygia of axillae (in some patients) n1=Xeroderma | n2=en:pterygia of axillae (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygia of digits, neck, axillae, antecubital, popliteal, intercrural areas n1=Xeroderma | n2=en:pterygia of digits, neck, axillae, antecubital, popliteal, intercrural areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygia of elbows (in some patients) n1=Xeroderma | n2=en:pterygia of elbows (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygia of groin (in some patients) n1=Xeroderma | n2=en:pterygia of groin (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygia of neck (in some patients) n1=Xeroderma | n2=en:pterygia of neck (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygium n1=Xeroderma | n2=en:pterygium | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygium (elbows and knees) n1=Xeroderma | n2=en:pterygium (elbows and knees) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygium of bilateral (in some patients) n1=Xeroderma | n2=en:pterygium of bilateral (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygium of elbow, bilateral (in some patients) n1=Xeroderma | n2=en:pterygium of elbow, bilateral (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pterygium of wrist, bilateral (in some patients) n1=Xeroderma | n2=en:pterygium of wrist, bilateral (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:punch-like skin defects n1=Xeroderma | n2=en:punch-like skin defects | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:punctate keratitis n1=Xeroderma | n2=en:punctate keratitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:punctate keratoses (palms and soles) n1=Xeroderma | n2=en:punctate keratoses (palms and soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:punctate palmoplantar hyperkeratosis (later onset) n1=Xeroderma | n2=en:punctate palmoplantar hyperkeratosis (later onset) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:punctate palmoplantar keratoderma n1=Xeroderma | n2=en:punctate palmoplantar keratoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:punctate vasculitis skin lesions n1=Xeroderma | n2=en:punctate vasculitis skin lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:purpura n1=Xeroderma | n2=en:purpura | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:purpuric rash n1=Xeroderma | n2=en:purpuric rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:purulent discharge n1=Xeroderma | n2=en:purulent discharge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pustular eruption n1=Xeroderma | n2=en:pustular eruption | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pustular lesion n1=Xeroderma | n2=en:pustular lesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pustulosis or pustular psoriasis, generalized n1=Xeroderma | n2=en:pustulosis or pustular psoriasis, generalized | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pyoderma n1=Xeroderma | n2=en:pyoderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pyoderma gangrenosum n1=Xeroderma | n2=en:pyoderma gangrenosum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:pyramidal skinfold of halluces n1=Xeroderma | n2=en:pyramidal skinfold of halluces | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:raised, firm, hairless posterior scalp nodules n1=Xeroderma | n2=en:raised, firm, hairless posterior scalp nodules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rales n1=Xeroderma | n2=en:rales | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rare skin cancers n1=Xeroderma | n2=en:rare skin cancers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rash (erythematous macules or papules) n1=Xeroderma | n2=en:rash (erythematous macules or papules) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rash erythematous n1=Xeroderma | n2=en:rash erythematous | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rash may or may not be pruritic n1=Xeroderma | n2=en:rash may or may not be pruritic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rash scaly n1=Xeroderma | n2=en:rash scaly | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rash, episodic n1=Xeroderma | n2=en:rash, episodic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rash, urticarial, episodic n1=Xeroderma | n2=en:rash, urticarial, episodic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:raynaud phenomenon n1=Xeroderma | n2=en:raynaud phenomenon | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:raynaud phenomenon (in some patients) n1=Xeroderma | n2=en:raynaud phenomenon (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reaction nonspecific n1=Xeroderma | n2=en:reaction nonspecific | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:recurrent bacterial skin infections n1=Xeroderma | n2=en:recurrent bacterial skin infections | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:recurrent cellulitis n1=Xeroderma | n2=en:recurrent cellulitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:recurrent shingles n1=Xeroderma | n2=en:recurrent shingles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:recurrent skin abscesses n1=Xeroderma | n2=en:recurrent skin abscesses | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:recurrent skin abscesses (1 patient) n1=Xeroderma | n2=en:recurrent skin abscesses (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:recurrent skin infections n1=Xeroderma | n2=en:recurrent skin infections | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:recurrent skin ulcerations (face, trunk, limbs) n1=Xeroderma | n2=en:recurrent skin ulcerations (face, trunk, limbs) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:red mucosa n1=Xeroderma | n2=en:red mucosa | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:red-violet macular atrophy n1=Xeroderma | n2=en:red-violet macular atrophy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:red, cracking, peeling skin at birth n1=Xeroderma | n2=en:red, cracking, peeling skin at birth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:red, raised, scaly skin patches (elbows, knees, scalp) n1=Xeroderma | n2=en:red, raised, scaly skin patches (elbows, knees, scalp) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reddish discoloration, episodic, associated with pain n1=Xeroderma | n2=en:reddish discoloration, episodic, associated with pain | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reddish or purplish skin discoloration, episodic, associated with pain n1=Xeroderma | n2=en:reddish or purplish skin discoloration, episodic, associated with pain | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reduced axillary apocrine secretion n1=Xeroderma | n2=en:reduced axillary apocrine secretion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reduced mobility n1=Xeroderma | n2=en:reduced mobility | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reduced skin elasticity n1=Xeroderma | n2=en:reduced skin elasticity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reduced subcutaneous adipose tissue n1=Xeroderma | n2=en:reduced subcutaneous adipose tissue | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reduced sweating of palms and soles n1=Xeroderma | n2=en:reduced sweating of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:redundant connective tissue n1=Xeroderma | n2=en:redundant connective tissue | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:redundant folds n1=Xeroderma | n2=en:redundant folds | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:redundant palmar skin n1=Xeroderma | n2=en:redundant palmar skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:redundant skin n1=Xeroderma | n2=en:redundant skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:redundant skin in infancy n1=Xeroderma | n2=en:redundant skin in infancy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:residual hyperpigmentation n1=Xeroderma | n2=en:residual hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:residual postinflammatory hyperpigmentation, moderate n1=Xeroderma | n2=en:residual postinflammatory hyperpigmentation, moderate | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:residual slightly atrophic scarring n1=Xeroderma | n2=en:residual slightly atrophic scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticular hyperpigmentation n1=Xeroderma | n2=en:reticular hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticular hyperpigmentation (neck) n1=Xeroderma | n2=en:reticular hyperpigmentation (neck) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticular pigmentation pattern n1=Xeroderma | n2=en:reticular pigmentation pattern | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticular skin pigmentation (classic feature, nola3 patient) n1=Xeroderma | n2=en:reticular skin pigmentation (classic feature, nola3 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulate hyperpigmentation (periocular, perioral, chest, neck, abdomen) n1=Xeroderma | n2=en:reticulate hyperpigmentation (periocular, perioral, chest, neck, abdomen) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulate hyperpigmentation (primarily trunk) n1=Xeroderma | n2=en:reticulate hyperpigmentation (primarily trunk) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulate hyperpigmentation composed of 1- to 5-mm light brown spots with clearly defined borders that may coalesce n1=Xeroderma | n2=en:reticulate hyperpigmentation composed of 1- to 5-mm light brown spots with clearly defined borders that may coalesce | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulate hyperpigmented macules which darken over time and appear initially on dorsa of hands and feet but progress to flexor aspects of proximal extremities n1=Xeroderma | n2=en:reticulate hyperpigmented macules which darken over time and appear initially on dorsa of hands and feet but progress to flexor aspects of proximal extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulate ichthyosis (in some patients) n1=Xeroderma | n2=en:reticulate ichthyosis (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulate pigmented skin abnormalities n1=Xeroderma | n2=en:reticulate pigmented skin abnormalities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulate skin pigmentation n1=Xeroderma | n2=en:reticulate skin pigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulated pigmentation (seen in recessive form) n1=Xeroderma | n2=en:reticulated pigmentation (seen in recessive form) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulated skin pigmentation, predominantly on face, neck, chest, arms (94% male patients) n1=Xeroderma | n2=en:reticulated skin pigmentation, predominantly on face, neck, chest, arms (94% male patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:reticulolinear skin defects over face and neck (4/4 patients) n1=Xeroderma | n2=en:reticulolinear skin defects over face and neck (4/4 patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rhytide of forehead n1=Xeroderma | n2=en:rhytide of forehead | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rough, thick palmar skin n1=Xeroderma | n2=en:rough, thick palmar skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:rubbery feel of the nose and chin n1=Xeroderma | n2=en:rubbery feel of the nose and chin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:s. epidermidis only microorganism isolated n1=Xeroderma | n2=en:s. epidermidis only microorganism isolated | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sacral dimple n1=Xeroderma | n2=en:sacral dimple | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sacral dimple (2 patients) n1=Xeroderma | n2=en:sacral dimple (2 patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sacral dimple (in some patients) n1=Xeroderma | n2=en:sacral dimple (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sacral striae n1=Xeroderma | n2=en:sacral striae | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scabies and other acariases n1=Xeroderma | n2=en:scabies and other acariases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scalding burn n1=Xeroderma | n2=en:scalding burn | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scales on scalp (in some patients) n1=Xeroderma | n2=en:scales on scalp (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scalp n1=Xeroderma | n2=en:scalp | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scalp defect n1=Xeroderma | n2=en:scalp defect | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scalp dryness n1=Xeroderma | n2=en:scalp dryness | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scalp erosions n1=Xeroderma | n2=en:scalp erosions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scalp sinus formation n1=Xeroderma | n2=en:scalp sinus formation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scaly skin n1=Xeroderma | n2=en:scaly skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scaly skin rash over the perineum n1=Xeroderma | n2=en:scaly skin rash over the perineum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scarring (late complication) n1=Xeroderma | n2=en:scarring (late complication) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:schwannoma n1=Xeroderma | n2=en:schwannoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scleredema adultorum n1=Xeroderma | n2=en:scleredema adultorum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sclerodactyly n1=Xeroderma | n2=en:sclerodactyly | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scleroderma n1=Xeroderma | n2=en:scleroderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scleroderma-like change n1=Xeroderma | n2=en:scleroderma-like change | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scleroderma-like secondary cutaneous sclerosis n1=Xeroderma | n2=en:scleroderma-like secondary cutaneous sclerosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scleroderma-like skin, especially of face and distal extremities n1=Xeroderma | n2=en:scleroderma-like skin, especially of face and distal extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sclerodermatous skin changes n1=Xeroderma | n2=en:sclerodermatous skin changes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sclerosis of digits (in some patients) n1=Xeroderma | n2=en:sclerosis of digits (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sclerotic soft tissue over affected bones n1=Xeroderma | n2=en:sclerotic soft tissue over affected bones | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:scrotum n1=Xeroderma | n2=en:scrotum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sebaceous cyst n1=Xeroderma | n2=en:sebaceous cyst | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sebaceous cysts (buttocks and perineum) n1=Xeroderma | n2=en:sebaceous cysts (buttocks and perineum) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sebaceous gland n1=Xeroderma | n2=en:sebaceous gland | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sebaceous gland tumors n1=Xeroderma | n2=en:sebaceous gland tumors | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sebaceous hyperplasia n1=Xeroderma | n2=en:sebaceous hyperplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:seborrhea (35% of adults) n1=Xeroderma | n2=en:seborrhea (35% of adults) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:seborrheic dermatitis n1=Xeroderma | n2=en:seborrheic dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:seborrheic dermatitis (1 family) n1=Xeroderma | n2=en:seborrheic dermatitis (1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:seborrheic dermatitis in infancy n1=Xeroderma | n2=en:seborrheic dermatitis in infancy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:seborrheic dermatitis of scalp n1=Xeroderma | n2=en:seborrheic dermatitis of scalp | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:seborrheic keratosis-like papules n1=Xeroderma | n2=en:seborrheic keratosis-like papules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:self-healing collodion baby (in some patients) n1=Xeroderma | n2=en:self-healing collodion baby (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:self-injury n1=Xeroderma | n2=en:self-injury | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sensitivity to cold with paresthesias n1=Xeroderma | n2=en:sensitivity to cold with paresthesias | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sensitivity to weather change n1=Xeroderma | n2=en:sensitivity to weather change | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:serum sickness-like reaction n1=Xeroderma | n2=en:serum sickness-like reaction | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:severe acne (23% of adults) n1=Xeroderma | n2=en:severe acne (23% of adults) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:severe atopic dermatitis n1=Xeroderma | n2=en:severe atopic dermatitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:severe bullous blistering lesions n1=Xeroderma | n2=en:severe bullous blistering lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:severe cystic acne n1=Xeroderma | n2=en:severe cystic acne | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:severe facial acne (in female patient) n1=Xeroderma | n2=en:severe facial acne (in female patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:severe photosensitivity n1=Xeroderma | n2=en:severe photosensitivity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:severe progressive ulceration of lower extremities n1=Xeroderma | n2=en:severe progressive ulceration of lower extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:shagreen patch n1=Xeroderma | n2=en:shagreen patch | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:shallow indolent cutaneous ulcers (in some patients) n1=Xeroderma | n2=en:shallow indolent cutaneous ulcers (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sharp midline demarcation n1=Xeroderma | n2=en:sharp midline demarcation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:shiny, taut, erythematous skin n1=Xeroderma | n2=en:shiny, taut, erythematous skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sick building syndrome n1=Xeroderma | n2=en:sick building syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:simian crease (in some patients) n1=Xeroderma | n2=en:simian crease (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:single palmar crease n1=Xeroderma | n2=en:single palmar crease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:single transverse palmar crease (in some patients) n1=Xeroderma | n2=en:single transverse palmar crease (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:single, bilateral, symmetric papular/nodular lesion in the midline plantar region of the heel (0.5 - 1 cm diameter) n1=Xeroderma | n2=en:single, bilateral, symmetric papular/nodular lesion in the midline plantar region of the heel (0.5 - 1 cm diameter) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:size variation (1 x 1 to 6 x 4 cm) n1=Xeroderma | n2=en:size variation (1 x 1 to 6 x 4 cm) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin n1=Xeroderma | n2=en:skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin absorption n1=Xeroderma | n2=en:skin absorption | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin appendage structure n1=Xeroderma | n2=en:skin appendage structure | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin appendages (periorbital, face, thorax, rarely on trunk) n1=Xeroderma | n2=en:skin appendages (periorbital, face, thorax, rarely on trunk) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin atrophy n1=Xeroderma | n2=en:skin atrophy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin atrophy (especially over hands and feet) n1=Xeroderma | n2=en:skin atrophy (especially over hands and feet) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin atrophy (over nose and scalp sutural areas) n1=Xeroderma | n2=en:skin atrophy (over nose and scalp sutural areas) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin atrophy over affected bones n1=Xeroderma | n2=en:skin atrophy over affected bones | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin basal cell carcinoma n1=Xeroderma | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin biopsy shows noncaseating granulomas n1=Xeroderma | n2=en:skin biopsy shows noncaseating granulomas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin blistering, intermittent n1=Xeroderma | n2=en:skin blistering, intermittent | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin blisters n1=Xeroderma | n2=en:skin blisters | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin blisters and erosions (neck, perianal, submaxillary, groin, axilla, popliteal fossa) n1=Xeroderma | n2=en:skin blisters and erosions (neck, perianal, submaxillary, groin, axilla, popliteal fossa) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin cell n1=Xeroderma | n2=en:skin cell | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin changes worse in areas of lower skin temperature n1=Xeroderma | n2=en:skin changes worse in areas of lower skin temperature | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin cyst n1=Xeroderma | n2=en:skin cyst | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin derivative n1=Xeroderma | n2=en:skin derivative | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin dimple (lower back) n1=Xeroderma | n2=en:skin dimple (lower back) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin dimple over apex of long bone angulation n1=Xeroderma | n2=en:skin dimple over apex of long bone angulation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin dimples on upper thighs (1 patient) n1=Xeroderma | n2=en:skin dimples on upper thighs (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin disease, vesicular n1=Xeroderma | n2=en:skin disease, vesicular | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin disorders: severe generalized n1=Xeroderma | n2=en:skin disorders: severe generalized | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin erosion n1=Xeroderma | n2=en:skin erosion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin fissure n1=Xeroderma | n2=en:skin fissure | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin fissures (groin, axilla, neck) n1=Xeroderma | n2=en:skin fissures (groin, axilla, neck) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin flushing, episodic, associated with pain n1=Xeroderma | n2=en:skin flushing, episodic, associated with pain | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin folds or creases (neck or forearm) n1=Xeroderma | n2=en:skin folds or creases (neck or forearm) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin foreign body n1=Xeroderma | n2=en:skin foreign body | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin fragility with non-scarring blistering n1=Xeroderma | n2=en:skin fragility with non-scarring blistering | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin hyperlaxity (males) n1=Xeroderma | n2=en:skin hyperlaxity (males) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin hyperpigmentation n1=Xeroderma | n2=en:skin hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin hypopigmentation n1=Xeroderma | n2=en:skin hypopigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin infection n1=Xeroderma | n2=en:skin infection | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin infection/inflammation n1=Xeroderma | n2=en:skin infection/inflammation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin lacks elastic recoil n1=Xeroderma | n2=en:skin lacks elastic recoil | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin lesions are usually symmetrical n1=Xeroderma | n2=en:skin lesions are usually symmetrical | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin lesions follow the lines of blaschko n1=Xeroderma | n2=en:skin lesions follow the lines of blaschko | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin may redden during episodes n1=Xeroderma | n2=en:skin may redden during episodes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin mottling due to poor perfusion n1=Xeroderma | n2=en:skin mottling due to poor perfusion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin necrosis n1=Xeroderma | n2=en:skin necrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin nodules - fingers, elbows, nose, ears (onset infancy-childhood) n1=Xeroderma | n2=en:skin nodules - fingers, elbows, nose, ears (onset infancy-childhood) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of female human body n1=Xeroderma | n2=en:skin of female human body | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of left lower limb n1=Xeroderma | n2=en:skin of left lower limb | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of left upper limb n1=Xeroderma | n2=en:skin of left upper limb | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of male human body n1=Xeroderma | n2=en:skin of male human body | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of right lower limb n1=Xeroderma | n2=en:skin of right lower limb | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of right upper limb n1=Xeroderma | n2=en:skin of right upper limb | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the axilla n1=Xeroderma | n2=en:skin of the axilla | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the extremity n1=Xeroderma | n2=en:skin of the extremity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the face n1=Xeroderma | n2=en:skin of the face | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the lip n1=Xeroderma | n2=en:skin of the lip | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the lower limb and hip n1=Xeroderma | n2=en:skin of the lower limb and hip | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the scalp and neck n1=Xeroderma | n2=en:skin of the scalp and neck | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the trunk n1=Xeroderma | n2=en:skin of the trunk | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin of the upper limb and shoulder n1=Xeroderma | n2=en:skin of the upper limb and shoulder | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin over joint surfaces of hands and feet is thick, red, and edematous n1=Xeroderma | n2=en:skin over joint surfaces of hands and feet is thick, red, and edematous | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin part n1=Xeroderma | n2=en:skin part | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin peeling/scaling (newborn) n1=Xeroderma | n2=en:skin peeling/scaling (newborn) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin photosensitivity n1=Xeroderma | n2=en:skin photosensitivity | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin pigmentation - finding n1=Xeroderma | n2=en:skin pigmentation - finding | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin pigmentation disorder n1=Xeroderma | n2=en:skin pigmentation disorder | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin rash n1=Xeroderma | n2=en:skin rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin rough n1=Xeroderma | n2=en:skin rough | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin structure of back n1=Xeroderma | n2=en:skin structure of back | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin tag n1=Xeroderma | n2=en:skin tag | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin tags on chest n1=Xeroderma | n2=en:skin tags on chest | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin tags on genitalia (in some patients) n1=Xeroderma | n2=en:skin tags on genitalia (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin tags on palms (in some patients) n1=Xeroderma | n2=en:skin tags on palms (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin tags on the upper part of the auricle n1=Xeroderma | n2=en:skin tags on the upper part of the auricle | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin ulcer n1=Xeroderma | n2=en:skin ulcer | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin vessels with inversion of the usual osmiophilic pattern on electron microscopy n1=Xeroderma | n2=en:skin vessels with inversion of the usual osmiophilic pattern on electron microscopy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:skin wrinkling (limited to dorsum of hands and feet and abdomen) n1=Xeroderma | n2=en:skin wrinkling (limited to dorsum of hands and feet and abdomen) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:slight erythema of face n1=Xeroderma | n2=en:slight erythema of face | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:slow-healing wounds due to painless injuries n1=Xeroderma | n2=en:slow-healing wounds due to painless injuries | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small areas of alopecia n1=Xeroderma | n2=en:small areas of alopecia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small conically shaped papules (1 to 3 mm in diameter) located on face, neck, trunk, and limbs n1=Xeroderma | n2=en:small conically shaped papules (1 to 3 mm in diameter) located on face, neck, trunk, and limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small hemorrhagic blisters on hands n1=Xeroderma | n2=en:small hemorrhagic blisters on hands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small nodular skin-tags n1=Xeroderma | n2=en:small nodular skin-tags | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small papules on sun-exposed areas n1=Xeroderma | n2=en:small papules on sun-exposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small pterygia (axillary, popliteal) n1=Xeroderma | n2=en:small pterygia (axillary, popliteal) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas n1=Xeroderma | n2=en:small, annular, anhidrotic keratotic lesions located predominantly on sun-exposed areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small, red lesion, may increase in size with age n1=Xeroderma | n2=en:small, red lesion, may increase in size with age | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:small, yellow papules (mouth, neck, axilla, elbows, groin, periumbilical region) n1=Xeroderma | n2=en:small, yellow papules (mouth, neck, axilla, elbows, groin, periumbilical region) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:smooth, thin, dry skin n1=Xeroderma | n2=en:smooth, thin, dry skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:smooth, waxy, thick skin over palms and soles, desquamating in large flakes n1=Xeroderma | n2=en:smooth, waxy, thick skin over palms and soles, desquamating in large flakes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft skin n1=Xeroderma | n2=en:soft skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft thin skin n1=Xeroderma | n2=en:soft thin skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft tissue calcinosis n1=Xeroderma | n2=en:soft tissue calcinosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft with easy bruising (in some patients) n1=Xeroderma | n2=en:soft with easy bruising (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft, doughy skin n1=Xeroderma | n2=en:soft, doughy skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft, redundant skin (especially facial) n1=Xeroderma | n2=en:soft, redundant skin (especially facial) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft, thin skin (1 family) n1=Xeroderma | n2=en:soft, thin skin (1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:soft, velvety skin n1=Xeroderma | n2=en:soft, velvety skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sparing of flexure areas, palms, and soles n1=Xeroderma | n2=en:sparing of flexure areas, palms, and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sparse axillary and facial hair n1=Xeroderma | n2=en:sparse axillary and facial hair | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spheroids n1=Xeroderma | n2=en:spheroids | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spiky hyperkeratosis n1=Xeroderma | n2=en:spiky hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spiny follicular plugging n1=Xeroderma | n2=en:spiny follicular plugging | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spiradenoma n1=Xeroderma | n2=en:spiradenoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:split anchoring plaques of desmosomes in the granular layer (transmission electron microscopy (tem)) n1=Xeroderma | n2=en:split anchoring plaques of desmosomes in the granular layer (transmission electron microscopy (tem)) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spontaneous hematomas n1=Xeroderma | n2=en:spontaneous hematomas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spontaneous, non-scarring healing n1=Xeroderma | n2=en:spontaneous, non-scarring healing | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spotted and reticulate pigmentation of flexural areas of skin n1=Xeroderma | n2=en:spotted and reticulate pigmentation of flexural areas of skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spotty hyperpigmentation n1=Xeroderma | n2=en:spotty hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:spotty hypopigmentation n1=Xeroderma | n2=en:spotty hypopigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:squamous epitheliomas, multiple n1=Xeroderma | n2=en:squamous epitheliomas, multiple | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:squamous pityriasiform appearance of scalp n1=Xeroderma | n2=en:squamous pityriasiform appearance of scalp | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stage 1 - skin erythema, vesicles, pustules n1=Xeroderma | n2=en:stage 1 - skin erythema, vesicles, pustules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stage 2 - skin papules, verrucous lesions, hyperkeratosis n1=Xeroderma | n2=en:stage 2 - skin papules, verrucous lesions, hyperkeratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stage 3 - skin hyperpigmentation n1=Xeroderma | n2=en:stage 3 - skin hyperpigmentation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stage 4 - skin pallor, atrophy, and scarring n1=Xeroderma | n2=en:stage 4 - skin pallor, atrophy, and scarring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:starfish-like acral keratoses (knuckles) n1=Xeroderma | n2=en:starfish-like acral keratoses (knuckles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stasis ulcers n1=Xeroderma | n2=en:stasis ulcers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:steatocystoma multiplex n1=Xeroderma | n2=en:steatocystoma multiplex | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:steatocystomas n1=Xeroderma | n2=en:steatocystomas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stenosis n1=Xeroderma | n2=en:stenosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sterile abscesses at site of parenteral injection n1=Xeroderma | n2=en:sterile abscesses at site of parenteral injection | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sterile pustules n1=Xeroderma | n2=en:sterile pustules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stevens-johnson syndrome n1=Xeroderma | n2=en:stevens-johnson syndrome | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stiff skin n1=Xeroderma | n2=en:stiff skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:streaks and whorls n1=Xeroderma | n2=en:streaks and whorls | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:stretched skin n1=Xeroderma | n2=en:stretched skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:striae n1=Xeroderma | n2=en:striae | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:striated keratoderma of palms (in some patients) n1=Xeroderma | n2=en:striated keratoderma of palms (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous calcification n1=Xeroderma | n2=en:subcutaneous calcification | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous connective tissue nevi n1=Xeroderma | n2=en:subcutaneous connective tissue nevi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous infections, recurrent, with fistula formation n1=Xeroderma | n2=en:subcutaneous infections, recurrent, with fistula formation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous lipoma n1=Xeroderma | n2=en:subcutaneous lipoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous lipomas, well-circumscribed and painful n1=Xeroderma | n2=en:subcutaneous lipomas, well-circumscribed and painful | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous lipomatous tissue n1=Xeroderma | n2=en:subcutaneous lipomatous tissue | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous nodule n1=Xeroderma | n2=en:subcutaneous nodule | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial) n1=Xeroderma | n2=en:subcutaneous nodules (interphalangeal joints, knees, feet, elbows, pretibial) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous nontender firm nodules n1=Xeroderma | n2=en:subcutaneous nontender firm nodules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous ossifications n1=Xeroderma | n2=en:subcutaneous ossifications | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous papules in infancy n1=Xeroderma | n2=en:subcutaneous papules in infancy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous scalp cysts n1=Xeroderma | n2=en:subcutaneous scalp cysts | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous spheroids n1=Xeroderma | n2=en:subcutaneous spheroids | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subcutaneous tumors, recurring n1=Xeroderma | n2=en:subcutaneous tumors, recurring | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subepidermal capillary ectasia n1=Xeroderma | n2=en:subepidermal capillary ectasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:subungual fibroma n1=Xeroderma | n2=en:subungual fibroma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sucking, thumb n1=Xeroderma | n2=en:sucking, thumb | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:superficial generalized lifelong skin peeling (sparing palms and soles) n1=Xeroderma | n2=en:superficial generalized lifelong skin peeling (sparing palms and soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:superficial skin peeling (limited to dorsa of hands and feet) n1=Xeroderma | n2=en:superficial skin peeling (limited to dorsa of hands and feet) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:superficial, firm, circumscribed nodule n1=Xeroderma | n2=en:superficial, firm, circumscribed nodule | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:suppurative scalp nodules n1=Xeroderma | n2=en:suppurative scalp nodules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:suprapubic skin n1=Xeroderma | n2=en:suprapubic skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:susceptibility n1=Xeroderma | n2=en:susceptibility | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sweat gland n1=Xeroderma | n2=en:sweat gland | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sweat gland diseases n1=Xeroderma | n2=en:sweat gland diseases | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sweat pore aplasia n1=Xeroderma | n2=en:sweat pore aplasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:sweating, episodic n1=Xeroderma | n2=en:sweating, episodic | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:swelling n1=Xeroderma | n2=en:swelling | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:symptom masked n1=Xeroderma | n2=en:symptom masked | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:symptom/complaint nails n1=Xeroderma | n2=en:symptom/complaint nails | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:symptom/complaint of skin texture n1=Xeroderma | n2=en:symptom/complaint of skin texture | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:systematized epidermal nevus n1=Xeroderma | n2=en:systematized epidermal nevus | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tan macules on glans penis and penile shaft n1=Xeroderma | n2=en:tan macules on glans penis and penile shaft | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tanning possible n1=Xeroderma | n2=en:tanning possible | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:taunt skin n1=Xeroderma | n2=en:taunt skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectases (especially on tongue, lips, palate, face, conjunctiva, trunk, nail beds, fingers, and finger pads) n1=Xeroderma | n2=en:telangiectases (especially on tongue, lips, palate, face, conjunctiva, trunk, nail beds, fingers, and finger pads) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectases (especially on tongue, lips, palate, fingers, face, conjunctiva, trunk, nail beds, and fingertips) n1=Xeroderma | n2=en:telangiectases (especially on tongue, lips, palate, fingers, face, conjunctiva, trunk, nail beds, and fingertips) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectases (palms, soles, scalp, scrotum, legs) n1=Xeroderma | n2=en:telangiectases (palms, soles, scalp, scrotum, legs) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectases in sun-exposed and nonexposed skin n1=Xeroderma | n2=en:telangiectases in sun-exposed and nonexposed skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectasia n1=Xeroderma | n2=en:telangiectasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectasia (soles) n1=Xeroderma | n2=en:telangiectasia (soles) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectasia on lips and oral mucosa n1=Xeroderma | n2=en:telangiectasia on lips and oral mucosa | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectasia on the cheeks n1=Xeroderma | n2=en:telangiectasia on the cheeks | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectasia, particularly of the fingerpads and lips n1=Xeroderma | n2=en:telangiectasia, particularly of the fingerpads and lips | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectasias in both sun-exposed and sun-protected areas n1=Xeroderma | n2=en:telangiectasias in both sun-exposed and sun-protected areas | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:telangiectatic lesions n1=Xeroderma | n2=en:telangiectatic lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tendency to overheat n1=Xeroderma | n2=en:tendency to overheat | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tendinous xanthomas presenting after age 20 years in heterozygotes, during first 4 years of life in homozygotes n1=Xeroderma | n2=en:tendinous xanthomas presenting after age 20 years in heterozygotes, during first 4 years of life in homozygotes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tenting - skin n1=Xeroderma | n2=en:tenting - skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:terminal agitation n1=Xeroderma | n2=en:terminal agitation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:terminal state n1=Xeroderma | n2=en:terminal state | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick calluses on soles of feet n1=Xeroderma | n2=en:thick calluses on soles of feet | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick facial skin n1=Xeroderma | n2=en:thick facial skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick skin n1=Xeroderma | n2=en:thick skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick skin (66%) n1=Xeroderma | n2=en:thick skin (66%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick skin (74%) n1=Xeroderma | n2=en:thick skin (74%) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick, calloused skin n1=Xeroderma | n2=en:thick, calloused skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick, indurated skin over entire body n1=Xeroderma | n2=en:thick, indurated skin over entire body | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick, loose, doughy skin n1=Xeroderma | n2=en:thick, loose, doughy skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick, relatively tight skin n1=Xeroderma | n2=en:thick, relatively tight skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thick, waxy skin of palms and soles with well-defined erythematous border n1=Xeroderma | n2=en:thick, waxy skin of palms and soles with well-defined erythematous border | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thickened nuchal skin fold n1=Xeroderma | n2=en:thickened nuchal skin fold | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thickened skin over flexor surface of proximal phalanges n1=Xeroderma | n2=en:thickened skin over flexor surface of proximal phalanges | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thickened skin over the elbows and along the fingers n1=Xeroderma | n2=en:thickened skin over the elbows and along the fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thickened, furrowed skin n1=Xeroderma | n2=en:thickened, furrowed skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thickening of skin on the plantar and palmar surfaces n1=Xeroderma | n2=en:thickening of skin on the plantar and palmar surfaces | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thickening of the skin over the palms and soles (nola3 patient) n1=Xeroderma | n2=en:thickening of the skin over the palms and soles (nola3 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin skin n1=Xeroderma | n2=en:thin skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin, dry skin n1=Xeroderma | n2=en:thin, dry skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin, hyperpigmented skin n1=Xeroderma | n2=en:thin, hyperpigmented skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin, hypotrophic skin n1=Xeroderma | n2=en:thin, hypotrophic skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin, translucent skin n1=Xeroderma | n2=en:thin, translucent skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin, transparent skin (hands and feet) n1=Xeroderma | n2=en:thin, transparent skin (hands and feet) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin, velvety skin n1=Xeroderma | n2=en:thin, velvety skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:thin, wrinkled skin n1=Xeroderma | n2=en:thin, wrinkled skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tight, glistening facial skin n1=Xeroderma | n2=en:tight, glistening facial skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tight, rigid skin n1=Xeroderma | n2=en:tight, rigid skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tight, shiny skin over the forearms and hands n1=Xeroderma | n2=en:tight, shiny skin over the forearms and hands | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tinea capitis, severe or recurrent n1=Xeroderma | n2=en:tinea capitis, severe or recurrent | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tissue adhesion n1=Xeroderma | n2=en:tissue adhesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tissue anoxia n1=Xeroderma | n2=en:tissue anoxia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tone does not appreciably change with age n1=Xeroderma | n2=en:tone does not appreciably change with age | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transgression of hyperkeratosis to dorsum of hands and feet (in some patients) n1=Xeroderma | n2=en:transgression of hyperkeratosis to dorsum of hands and feet (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transgressive keratosis n1=Xeroderma | n2=en:transgressive keratosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transient eczema n1=Xeroderma | n2=en:transient eczema | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transient erysipelas-like erythematous rash n1=Xeroderma | n2=en:transient erysipelas-like erythematous rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transient painful erysipelas-like lesions on lower leg and ankle n1=Xeroderma | n2=en:transient painful erysipelas-like lesions on lower leg and ankle | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transient, migratory sharply outlined erythema (in some patients) n1=Xeroderma | n2=en:transient, migratory sharply outlined erythema (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transitional zone of cells with gradual loss of nuclei n1=Xeroderma | n2=en:transitional zone of cells with gradual loss of nuclei | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transplanted skin n1=Xeroderma | n2=en:transplanted skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:transverse distal crease across palm n1=Xeroderma | n2=en:transverse distal crease across palm | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:trichilemmal cyst n1=Xeroderma | n2=en:trichilemmal cyst | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:trichoepithelioma (brown, flat-topped papules) (rare) n1=Xeroderma | n2=en:trichoepithelioma (brown, flat-topped papules) (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:trichoepitheliomas, multiple (usually occur in the nasolabial folds, nose, or face) n1=Xeroderma | n2=en:trichoepitheliomas, multiple (usually occur in the nasolabial folds, nose, or face) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:trichoepitheliomas, multiple (usually occur in thenasolabial folds, the nose, and upper lip) n1=Xeroderma | n2=en:trichoepitheliomas, multiple (usually occur in thenasolabial folds, the nose, and upper lip) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tuberous xanthoma n1=Xeroderma | n2=en:tuberous xanthoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tumors appear most often on sun-exposed regions n1=Xeroderma | n2=en:tumors appear most often on sun-exposed regions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tumors are locally invasive n1=Xeroderma | n2=en:tumors are locally invasive | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tumors leave pitting scars n1=Xeroderma | n2=en:tumors leave pitting scars | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tumors undergo spontaneous resolution over a period of months n1=Xeroderma | n2=en:tumors undergo spontaneous resolution over a period of months | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:tylosis n1=Xeroderma | n2=en:tylosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ulceration n1=Xeroderma | n2=en:ulceration | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ulcerations of distal extremities n1=Xeroderma | n2=en:ulcerations of distal extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ulcers often lead to infection and amputation n1=Xeroderma | n2=en:ulcers often lead to infection and amputation | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ulcers, distal, due to sensory neuropathy n1=Xeroderma | n2=en:ulcers, distal, due to sensory neuropathy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ulcers, distal, painless, due to sensory neuropathy n1=Xeroderma | n2=en:ulcers, distal, painless, due to sensory neuropathy | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:ulcers, plantar n1=Xeroderma | n2=en:ulcers, plantar | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:umbilical bleeding after birth n1=Xeroderma | n2=en:umbilical bleeding after birth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:unevaluable event n1=Xeroderma | n2=en:unevaluable event | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:unilateral erythema and scaling (present at birth or soon after birth, face is spared) n1=Xeroderma | n2=en:unilateral erythema and scaling (present at birth or soon after birth, face is spared) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:unmasking of previously unidentified disease n1=Xeroderma | n2=en:unmasking of previously unidentified disease | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:unprovoked bruising n1=Xeroderma | n2=en:unprovoked bruising | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:uric acid tophi n1=Xeroderma | n2=en:uric acid tophi | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:urticaria n1=Xeroderma | n2=en:urticaria | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:urticaria due to cold n1=Xeroderma | n2=en:urticaria due to cold | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:urticaria pigmentosa or cutaneous mastocytosis (in patients with kit mutations) n1=Xeroderma | n2=en:urticaria pigmentosa or cutaneous mastocytosis (in patients with kit mutations) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:urticaria pigmentosa/maculopapular cutaneous mastocytosis n1=Xeroderma | n2=en:urticaria pigmentosa/maculopapular cutaneous mastocytosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:usually occurs in the head and neck area n1=Xeroderma | n2=en:usually occurs in the head and neck area | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:usually present on skin of neck, shoulders, or trunk n1=Xeroderma | n2=en:usually present on skin of neck, shoulders, or trunk | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:variable involvement of palms and soles n1=Xeroderma | n2=en:variable involvement of palms and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:variable number of lesions (1 to greater than 10) n1=Xeroderma | n2=en:variable number of lesions (1 to greater than 10) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:variable skin syndactyly fingers and toes n1=Xeroderma | n2=en:variable skin syndactyly fingers and toes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:varicose vein n1=Xeroderma | n2=en:varicose vein | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:varicose veins (reported in 1 family) n1=Xeroderma | n2=en:varicose veins (reported in 1 family) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vasculitis n1=Xeroderma | n2=en:vasculitis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vasculitis rash n1=Xeroderma | n2=en:vasculitis rash | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:velvety skin n1=Xeroderma | n2=en:velvety skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:velvety texture n1=Xeroderma | n2=en:velvety texture | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:velvety, smooth skin n1=Xeroderma | n2=en:velvety, smooth skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:venous angiectasia n1=Xeroderma | n2=en:venous angiectasia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vernix-like skin covering, present at birth, shed during first month of life (in some patients) n1=Xeroderma | n2=en:vernix-like skin covering, present at birth, shed during first month of life (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:verruca plantaris n1=Xeroderma | n2=en:verruca plantaris | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:verruca vulgaris n1=Xeroderma | n2=en:verruca vulgaris | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:verrucae (warts), multiple n1=Xeroderma | n2=en:verrucae (warts), multiple | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:verrucous lesion n1=Xeroderma | n2=en:verrucous lesion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vertical crease in fourth interdigital space n1=Xeroderma | n2=en:vertical crease in fourth interdigital space | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vertical creases of plantar surface between first and second toes n1=Xeroderma | n2=en:vertical creases of plantar surface between first and second toes | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vesicles on scalp and skin filled with clear fluid and less than 1cm in diameter n1=Xeroderma | n2=en:vesicles on scalp and skin filled with clear fluid and less than 1cm in diameter | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vesicles, congenital, on fingers and soles n1=Xeroderma | n2=en:vesicles, congenital, on fingers and soles | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vesicular lesions (inflammatory type b) n1=Xeroderma | n2=en:vesicular lesions (inflammatory type b) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vesicular lesions, congenital bilateral, between ear and corner of mouth n1=Xeroderma | n2=en:vesicular lesions, congenital bilateral, between ear and corner of mouth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vesiculo-bullous n1=Xeroderma | n2=en:vesiculo-bullous | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vesiculopustular lesions n1=Xeroderma | n2=en:vesiculopustular lesions | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vessels may form rounded nodules ('tufts') n1=Xeroderma | n2=en:vessels may form rounded nodules ('tufts') | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vitiligo n1=Xeroderma | n2=en:vitiligo | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vitiligo (1 patient) n1=Xeroderma | n2=en:vitiligo (1 patient) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:vitiligo (rare) n1=Xeroderma | n2=en:vitiligo (rare) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:warfarin-induced skin necrosis n1=Xeroderma | n2=en:warfarin-induced skin necrosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:warts, generalized (in some patients) n1=Xeroderma | n2=en:warts, generalized (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:warty thickening of flexural skin n1=Xeroderma | n2=en:warty thickening of flexural skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:well-circumscribed areas of nontender denuded skin on extremities n1=Xeroderma | n2=en:well-circumscribed areas of nontender denuded skin on extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:well-circumscribed peeling of the skin on the hands, feet and neck (easily elicited by moisture and minor trauma) n1=Xeroderma | n2=en:well-circumscribed peeling of the skin on the hands, feet and neck (easily elicited by moisture and minor trauma) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:well-defined erythematous border n1=Xeroderma | n2=en:well-defined erythematous border | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:white ash leaf-shaped macules n1=Xeroderma | n2=en:white ash leaf-shaped macules | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:white at birth n1=Xeroderma | n2=en:white at birth | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:white dermatographism n1=Xeroderma | n2=en:white dermatographism | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:white scaling skin, most prominent over upper and lower extremities n1=Xeroderma | n2=en:white scaling skin, most prominent over upper and lower extremities | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:white skin n1=Xeroderma | n2=en:white skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wide, thin scars n1=Xeroderma | n2=en:wide, thin scars | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:winter itch n1=Xeroderma | n2=en:winter itch | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wound discharge n1=Xeroderma | n2=en:wound discharge | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wound healing normal n1=Xeroderma | n2=en:wound healing normal | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wrinkled abdominal skin n1=Xeroderma | n2=en:wrinkled abdominal skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wrinkled face n1=Xeroderma | n2=en:wrinkled face | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wrinkled skin over dorsa of fingers n1=Xeroderma | n2=en:wrinkled skin over dorsa of fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wrinkled skin over fingers n1=Xeroderma | n2=en:wrinkled skin over fingers | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wrinkling of skin on limbs n1=Xeroderma | n2=en:wrinkling of skin on limbs | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wrinkly skin n1=Xeroderma | n2=en:wrinkly skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:wrinkly skin (13 of 22) n1=Xeroderma | n2=en:wrinkly skin (13 of 22) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xanthoma n1=Xeroderma | n2=en:xanthoma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xanthomas (in some patients) n1=Xeroderma | n2=en:xanthomas (in some patients) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xeroderma n1=Xeroderma | n2=en:xeroderma | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xeroderma of eyelid n1=Xeroderma | n2=en:xeroderma of eyelid | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xeroderma pigmentosum n1=Xeroderma | n2=en:xeroderma pigmentosum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xerodermia n1=Xeroderma | n2=en:xerodermia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xerosis n1=Xeroderma | n2=en:xerosis | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xerosis (buttocks, extensor surfaces of extremities) n1=Xeroderma | n2=en:xerosis (buttocks, extensor surfaces of extremities) | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:xerostomia n1=Xeroderma | n2=en:xerostomia | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:yellow complexion n1=Xeroderma | n2=en:yellow complexion | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:yellow subcutaneous tissue covered by thin, scaly skin n1=Xeroderma | n2=en:yellow subcutaneous tissue covered by thin, scaly skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:yellow-orange colored skin n1=Xeroderma | n2=en:yellow-orange colored skin | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> en:yellow, papular lesions of the lip, soft palate, pharynx n1=Xeroderma | n2=en:yellow, papular lesions of the lip, soft palate, pharynx | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> ichthyose n1=Xeroderma | n2=ichthyose | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> ichtyose n1=Xeroderma | n2=ichtyose | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> ichtyoses n1=Xeroderma | n2=ichtyoses | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> kératose folliculaire due à l'avitaminose a n1=Xeroderma | n2=kératose folliculaire due à l'avitaminose a | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> médecine n1=Xeroderma | n2=médecine | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> pathologie n1=Xeroderma | n2=pathologie | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> peau n1=Xeroderma | n2=peau | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> processus pathologique n1=Xeroderma | n2=processus pathologique | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> sécheresse n1=Xeroderma | n2=sécheresse | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> Xeroderma pigmentosum n1=Xeroderma | n2=Xeroderma pigmentosum | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> xérodermie n1=Xeroderma | n2=xérodermie | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> xérodermie due à l'avitaminose a n1=Xeroderma | n2=xérodermie due à l'avitaminose a | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 20 / 0.667 -> xérose n1=Xeroderma | n2=xérose | rel=r_associated | relid=0 | w=20 Xeroderma -- r_associated #0: 10 / 0.333 -> xeroderma pigmentosum et déficience mentale n1=Xeroderma | n2=xeroderma pigmentosum et déficience mentale | rel=r_associated | relid=0 | w=10 Xeroderma -- r_associated #0: 10 / 0.333 -> xérodermite pigmentaire n1=Xeroderma | n2=xérodermite pigmentaire | rel=r_associated | relid=0 | w=10

≈ 4 relations entrantes en:xeroderma pigmentosum --- r_associated #0: 60 --> Xeroderma n1=en:xeroderma pigmentosum | n2=Xeroderma | rel=r_associated | relid=0 | w=60 xeroderma pigmentosum --- r_associated #0: 60 --> Xeroderma n1=xeroderma pigmentosum | n2=Xeroderma | rel=r_associated | relid=0 | w=60 Xeroderma pigmentosum --- r_associated #0: 58 --> Xeroderma n1=Xeroderma pigmentosum | n2=Xeroderma | rel=r_associated | relid=0 | w=58 xérodermite pigmentaire --- r_associated #0: 10 --> Xeroderma n1=xérodermite pigmentaire | n2=Xeroderma | rel=r_associated | relid=0 | w=10